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mRNA degradation is important in post-transcriptional gene regulation. There are 
two major mRNA decay pathways in eukaryotes, both initiated by the shortening of 
the poly(A) tail in the 3’ end of mRNA. After deadenylation, the transcript can be 
degraded in the 3’ pathway by the exosome complex. Alternatively, it can be 
degraded in a 5’ pathway, in which the 5’ guanosine cap is removed by the decapping 
enzyme and the transcript is hydrolyzed by the 5’→3’ exonuclease. The enzymes and 
factors involved in the 5’ decay pathway are co-localized into the cytoplasmic 
processing bodies, whereby nonsense-mediated mRNA decay and RNA interference 
also take place. As a rate-limiting step of 5’ decay pathway, the decapping reaction is 
carried out by the Dcp1-Dcp2 holoenzyme. Dcp2 is a Nudix pyrophosphatase and 
Dcp1 stimulates the activity of Dcp2. The crystal structures of yeast Dcp1 and Dcp2 
proteins are presented in this study.  
The structure of the S.cerevisiae Dcp1 protein shows that it resembles the EVH1 
domain, a protein-protein interaction module. Two highly conserved patches have 
been identified on the surface of Dcp1p: one corresponds to the ligand recognition site 
of the EVH1 family and the other is specific to Dcp1 proteins. Biochemical assays 
demonstrated that these two patches are not required for direct Dcp2p binding but it 
could be a putative binding site for other regulators.  
The N-terminal 300 residues of S.cerevisiae Dcp2p are necessary and sufficient 
for mRNA decapping. The crystal structure of the corresponding region of S. pombe 
Dcp2(1-266) shows that it consists of an N-terminal helical domain followed by a 
Nudix domain. The Nudix domain is the catalytic domain, containing a Nudix motif 
characteristic of this family of pyrophosphatases. Mutagenesis study confirmed the 
 V
significance of two glutamic acid residues, Glu143 and Glu147, inside the Nudix 
motif. A third glutamic acid residue, Glu192, critical for decapping and outside of the 
Nudix motif was also identified based on structural analysis. The N-terminal domain 
is indispensable for mRNA turnover in vivo. In vitro, this region not only contributes 
to the decapping activity of the Nudix domain but also mediates the Dcp1-Dcp2 
complex formation. A portion of the large conserved patch on the Dcp2 N-terminal 
domain was identified to be critical for Dcp1p binding by GST pull-down assay. The 
equivalent residues in S. cerevisiae Dcp2p critical for Dcp1p binding was 
demonstrated by yeast two-hybrid. Importantly, the association of Dcp1p to the N-
terminal domain of Dcp2 is shown to be required for the stimulation of the Dcp2 
protein activity.  
The crystal structure of S. pombe Dcp1p in complex with the N-terminal domain 
of Dcp2p confirmed the previous finding that the highly conserved residues on Dcp2 
N-terminal domain are cricital for Dcp1p binding.  In contrast to Dcp2p, Dcp1p binds 
to Dcp2p using mainly variant residues, suggesting that the direct interaction of 
Dcp1p with Dcp2p is not conserved across species, consistent with the notion that the 
binding of Dcp1 to Dcp2 in higher eukaryotes requires an additional factor. Based on 
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1.1 mRNA turnover 
Genetic information is stored in DNA sequences, which are transcribed into 
messenger RNA (mRNA) intermediates and then translated into proteins to carry out 
biological functions. Gene expression is subjected to precise control at multiple levels 
and modulating mRNA biogenesis is one of them. mRNA biogenesis is regulated at 
various steps, including transcription, processing, transport, translation and 
degradation.  
 
1.1.1 The life cycle of mRNA 
In prokaryotes, due to the lack of compartmentalization in the cell, mRNA 
transcription, translation and degradation events are closely linked and take place in 
the cytosol. Prokaryotic genes are frequently arranged in tandem and transcribed into 
polycistronic mRNAs by the RNA polymerase.  The nascent mRNA product is 
primary, serving directly as the template for translation. Protein synthesis is carried 
out by ribosomes, which are attached to mRNA to initiate translation co-
transcriptionally.  Due to the lack of protection, prokaryotic mRNAs are usually 
unstable and quickly degraded.  
In eukaryotes, the fundamental process of mRNA metabolism resembles that of 
the prokaryotes, yet is more complex and regulated on individual steps (shown in 
Figure 1). 
Transcription.  There are several RNA polymerases in eukaryotes for the 
transcription of different types of RNAs: ribosomal RNA (rRNA), transfer RNA 
(tRNA) or messenger RNA (mRNA). The RNA polymerase II (RNAP II) is 
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responsible for transcribing a protein-coding gene into mRNA. Facilitated by 
transcription factors, RNAP II recognizes the promoter region of a gene and 




Figure 1. The life cycle of eukaryotic mRNA. mRNA is transcribed by the RNA 
polymerase II in the nucleus. The pre-mRNA is capped at the 5’ end and 
polyadenylated at the 3’ end. Intron-containing pre-mRNA is spliced to form the 
mature mRNA, which is exported into the cytoplasm for translation and 
destruction. Figure is modified from Aguilera, 2005. 
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The pre-mRNA has to undergo several processing events to be functional, 
including (1) 5’ modification with a cap structure, (2) 3’ cleavage and 
polyadenylation and (3) splicing out the non-coding intron region.  The carboxyl 
terminal domain (CTD) of the largest subunit of RNAP II is the binding platform of 
multiple RNA transcription and processing factors, providing a coordinated and 
efficient streamline for mRNA metabolism co-transcriptionally (Bentley, 2005; 
Proudfoot et al., 2002).  
5’ cap formation. mRNA capping enzymes that belong to the first group of 
processing factors recruited to RNAP II CTD comprise three kinds of enzymatic 
activities: RNA 5’ triphosphatase, guanylyltransferase and methyltransferase activities. 
Together they produce the cap structure consists of a 7-methylated guanosine residue 
linked to the initial nucleotide by a 5’-5’ triphosphate bridge, which is added to the 
growing transcript when it is only 22-25 nucleotides in length. Once the 5’ cap 
emerges, it is co-transcriptionally bound by the cap-binding complex (CBC), which is 
also attached to phosphorylated RNAP II CTD. CBC not only protects the stability of 
the 5’ terminus of the transcript but also participates in an interaction network to 
ensure the coordination of the following processing steps.  
3’ end formation. Following transcription, a highly conserved AAUAAA 
element or other downstream sequence elements in the 3’ un-translated region (UTR) 
of the pre-mRNA will mediate the specific cleavage by the cleavage and 
polyadenylation specificity factor (CPSF). Subsequently, activated by CPSF, the 
poly(A) polymerase generates a stretch of 200 adenine nucleotides tail at the 3’ 
terminus of the pre-mRNA molecule. Poly(A) sequences are coated with multiple 
copies of poly(A) binding proteins (PABP) that prevents mRNA trimming at the 3’ 
end.  In the cytoplasm, both 5’ and 3’ ends of the mRNA molecule are connected 
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through protein-protein interaction to form a closed-loop structure, which contributes 
to translation efficiency and mRNA stability  
Splicing. One distinguishing feature of eukaryotic organisms is that most genes 
are segmented, comprising of alternating non-expressed (intron) and expressed (exon) 
regions. For intron-containing transcripts, the intron regions in pre-mRNA must be 
removed by spliceosome to generate mature mRNA.  Splicing occurs in two steps: the 
formation of a free 5’ exon splicing site and a lariat-shaped molecule with the intron, 
the joining of two exon sequences and the splicing of the intron region. The reactions 
are catalyzed by a group of conserved small nuclear RNAs (snRNAs) in the small 
nuclear ribonucleoprotein particle (snRNP). The mRNA splicing event also deposits 
the exon-junction complex (EJC) about 20-24 nucleotides upstream of the exon-exon 
junction which plays a critical role in censoring transcript quality (Lejeune & Maquat, 
2005).  
Export. Properly processed mRNA is competent for export through the nuclear 
pore into the cytoplasm. The conserved TREX (transcription-export) complex is 
recruited to the 5’ end of mRNA co-transcriptionally or coupled with splicing events, 
and mediates the messenger ribonucleoprotein particle (mRNP) to nuclear pore 
complex (NPC) via its interaction with the export receptor. Generally, mRNA moves 
through the NPC by diffusion, although certain proteins may facilitate the transport by 
pulling the mRNP from the cytoplasmic side of NPC (Cheng et al., 2006; Aguilera, 
2005).  
Translation.  Translating mRNA into a protein includes four steps: translation 
initiation, elongation, termination and ribosome recycling. At the 5’ end of mRNA, 
the translation initiation complex eIF4F binds to the cap and recruits the 40S 
ribosomal subunit to the transcript. When the first initiation codon is encountered, the 
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60S ribosomal subunit joins the 40S subunit to form an 80S ribosome. The ribosome 
decodes the mRNA triplet and catalyzes the formation of a peptide bond.  The 
growing polypeptide chain exits the ribosome and the elongation cycle continues until 
a stop codon is encountered. The translation release factors eRF1 and eRF3 are 
responsible for recognizing the stop signals and subsequent hydrolysis of peptidyl-
tRNA to release the polypeptide chain from ribosome.  At the final step, the 
ribosomes will be recycled and engaged in the next round of protein synthesis (Kapp 
and Lorsch, 2004). 
Degradation. After rounds of translation, mRNA is finally destabilized and 
degraded.  mRNA decay is generally initiated by the removal of the poly(A) tail, 
thereafter the mRNA body is subjected to exonucleolytic digestion from either the 5’ 
end or 3’ end.  The mechanism and regulation of mRNA decay will be addressed in 
the following chapter.  
 
1.1.2 Biological significance of mRNA decay 
As the final step of mRNA metabolism, degradation is an important point for 
converging input stimuli to control the quantity and quality of mRNA. Firstly, the 
half-lives of eukaryotic mRNAs may vary up to three orders of magnitude and they 
are correlated with the physical functions of encoded proteins (Sachs, 1993; Wang et 
al., 2002a). For example, the transcripts of structural proteins tend to have longer half-
lives, while the transcripts of proteins in signaling pathways usually have short half-
lives, resulting in different amounts of proteins produced. Moreover, factors from the 
same stoichiometric complex have synchronized mRNA half-lives. The level of 
steady-state mRNA can also be swiftly altered by regulated transcription or 
degradation upon environmental changes or at specific developmental stages since it 
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is an efficient way for prompt response. Thus, mRNA degradation is both important 
in modulating the basal level of gene expression and as a means of gene regulation. 
Secondly, errors may arise from the transcription or splicing process and result in the 
accumulation of aberrant transcripts. These transcripts might contain abnormal 
features such as a stop codon occurring too soon or too late, or exhibit a hindering 
secondary structure. In cells, specific surveillance systems are employed to 
discriminate aberrant mRNAs from normal ones and escort erroneous mRNAs for 
rapid destruction. By doing this, it reduces the risk of generating toxic proteins or 
jamming the translational machinery (Clement and Lykke-Andersen, 2006).  
Moreover, the mRNA decay machinery is closely related to the RNA interference 
system and together plays an important role in gene regulation and antiviral immunity 
(Anderson, 2005). 
 
1.1.3 General mRNA decay pathways 
mRNAs are degraded via three general decay pathways in eukaryotic organisms: 
deadenylation-dependent 5’-3’ pathway, deadenylation-dependent 3’-5’ pathway and 
deadenylation-independent endonucleolytic pathway (Figure 2). These pathways co-
exist in various species, although the contribution of an individual pathway may be 
different (Coller and Parker, 2004). 
The majority of mRNAs are degraded in a deadenylation-dependent mode, in 
which the poly(A) tail shortening is the first and rate-limiting step in these pathways 
(Decker and Parker, 1993). The reaction is carried out by progressive deadenylases 
such as Ccr4p/Pop2p complex, Pan2/3p complex and PARN in different organisms 
(Korner et al., 1998; Daugeron et al., 2001).  When the residual poly(A) tail is less 
than 10 nucleotides, it is no longer stabilized by the poly(A) binding proteins. The 
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deadenylated transcript can then be processed from both ends. From the 5’ end,  the 7-
methylated guanosine cap is removed by the decapping enzymes Dcp1-Dcp2 complex 
(Beelman et al., 1996; Dunckley and Parker, 1999; Lykke-Andersen, 2002; Wang et 
al., 2002b; van Dijk et al., 2002). Decapping is also a rate-limiting step and the 
resulting transcript body is rapidly digested by the 5’ exonuclease Xrn1 (Muhlrad et 
al., 1994). Alternatively, deadenylated transcripts can be degraded from the 3’ end. 
The 3’ pathway requires the exosome, which is a complex containing multiple 3' to 5' 
exoribonucleases and RNA binding proteins (Allmang et al., 1999; Mitchell et al., 
1997). Together with the Ski complex (including Ski2p, Ski3p, Ski8p and the adapter 
Ski7p), exosome degrades mRNA to release the cap and the remaining mRNA of only 
a few nucleotides in length (Anderson and Parker, 1998; Araki et al., 2001).  The 
residual cap structure is further digested by the scavenger decapping enzyme DcpS 
(Liu et al., 2002). 
The 5’ and 3’ pathways co-exist and neither is indispensable but inhibiting both is 
synthetically lethal (Anderson and Parker, 1998). The relative contribution of either 
pathway may differ with regard to a specific transcript or organism. In yeast, the 5’ 
pathway is proposed to be the primary mRNA decay pathway as several mRNAs that 
have been extensively examined are degraded in this way. In line with this, the 
blockage of the 5’ pathway leads to the accumulation of transcripts (Muhrald et al., 
1994; Decker and Parker, 1993). Yeast mRNAs can also be degraded via the 3’ 
pathway, albeit at a much slower rate.  In human, the 3’ pathway is probably the 
dominant one as there are more capped decay intermediates than polyadenylated ones 
( Wang and Kiledjian, 2001).   
Endonucleolytic digestion, is a minor decay pathway and has been reported in a 
number of vertebrate mRNAs (Dodson and Shapiro, 2002). Endoribonucleolytic 
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cleavage can be mediated by specific cis-elements in the 3’UTR of mRNAs, such as 
the mammalian insulin-like growth factor, transferrin receptor, Xenopus serum 
albumin and α-globin; or within the coding region in other mRNAs. Many 
endonucleases remain obscure and only a few specific enzymes have been identified, 
such as GAP-SH3-binding protein that cleaves c-myc (Gallouzi et al., 1998) and 
PMR1 that cleaves single-stranded RNA at UG sites (Chernokalskaya et al., 1998).  
 
Figure 2. The general mRNA decay pathways in eukaryotes.  The majority of 
mRNAs are degraded is initiated with the shortening of the poly(A) tail. The 
deadenylated transcript can be processed from the 5’-3’ direction, in which it is 
decapped by Dcp1/Dcp2 complex, followed by 5’ exonuclease Xrn1 digestion. 
Alternatively, the deadenylated transcript can be degraded by the 3’ exonuclease 
complex of exosome. And the resulting short capped mRNA is further degested 
by the scavenger decapping enzyme DcpS. Certain mRNA can be degraded in a 
deadenylation-independent endonucleolytic pathway. This figure is modified 







1.1.4  Specialized mRNA decay pathways 
Enzymes and co-factors in the general mRNA decay pathway are also involved in 
mRNA surveillance systems to guarantee the quality of transcripts. Several 
specialized pathways have been identified, including the nonsense-mediated mRNA 
decay (NMD), non-stop decay (NSD) and no-go decay (NGD) pathways (Conti and 
Izaurralde, 2005; Clement and Lykke-Andersen, 2006; Vasudevan et al., 2002; 
Figure 3). 
 NMD. NMD is triggered when a transcript contains a premature translation 
termination codon (PTC). The existence of a PTC may lead to the production of a 
non-functional or truncated protein that has a dominant-negative effect. The NMD 
surveillance complex recognizes PTC and recruits the degradation machinery to 
eliminate the PTC-containing mRNA rapidly, in order to prevent the formation of a 
potentially toxic protein.  
The core of the surveillance complex is found to contain Upf1, Upf2 and Upf3 
factors, which are highly conserved across species. In yeast, the PTC definition 
mechanisms are independent of splicing, since most genes are without introns. Certain 
mRNAs contain loosely-defined downstream sequence elements (DSE), which are 
analogous to the exon-exon junction (Ruiz-Echevarria et al., 1998). NMD is also 
triggered by the abnormal context of 3’UTR, probably due to inefficient ribosome 
release (Amrani et al., 2004).   
In mammals, splicing events deposit the EJC on 20-24 nucleotides upstream of the 
exon-exon boundary. Normally, an EJC is dissociated from mRNA during the 
translation elongation. However, if a stop codon resides 50 nucleotides upstream of 
the last exon-exon junction, translation fails to remove the EJC. Proteins in EJC are 
able to elicit NMD factors to form the NMD-activating mRNP and induce mRNA 
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degradation. In higher eukaryotes, in addition to the core EJC complex, a group of 
SMG1, SMG5, SMG6 and SMG7 proteins are required for proper regulation (Conti 
and Izaurralde, 2005). 
The NMD factors can interact with the mRNA decay machinery and target mRNA 
for decapping and Xrn1 digestion without poly(A) tail shortening (Lejeune and 
Maquat, 2005; Muhlrad and Parker, 1999). Alternatively, mRNA can undergo rapid 
deadenylation and be degraded by the exosome and Ski complex (Mitchell and 
Tollervey, 2000).  In Drosophila, endonucleolytic cleavage has been reported and 
resulting fragments are degraded by the exosome from the 3’ end and Xrn1 from the 
5’ end (Gatfield and Izaurralde, 2004).   
NSD. A second mechanism to degrade transcripts lacking stop codon, termed non-
stop decay (NSD), is identified in both yeast and mammalian systems. The absence of 
stop codon disrupts the normal context of 3’ UTR and interferes with the normal 
dissociation of ribosome, leading to stalled ribosomes at the 3’ end. NSD-targeted 
transcripts are degraded via deadenylation and the 3’ pathway, as the exosome and 
Ski7p are essential in eliminating the aberrant mRNAs (van Hoof and Parker, 2002; 
Frischmeyer et al., 2002).  Interestingly, the C-terminal region of Ski7p is analogous 
to the translation termination factor eRF3, a GTPase, indicating that Ski7p may recruit 
the exosome to the transcript by recognizing the empty A site of the ribosome.  
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 Figure 3. mRNA surveillance pathways.  a) the mRNA containing premature stop 
codon is recognized by NMD factors and degraded via 5’ and 3’ exonucleolytic 
pathways. b) mRNA without stop codon is degraded via 3’ exonucleolytic pathway. 
c) mRNA with a hindering secondary structure is recognized by no-go decay factors 
and digested by an endonuclease.  Figure is modified from Clement and Lykke-
Andersen, 2006.  
NGD. The third type of mRNA quality control is no-go decay (NGD). The 
presence of a stable secondary structure in the mRNA or a faulty ribosome defective 
in dissociation can stall ribosomes during translation elongation. In this case, the 
mRNAs are also promptly eliminated (Doma and Parker, 2006). Two proteins, 
Dom34p and Hbs1p, are important in recognizing stalled ribosomes in yeast NGD.  
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Hbs1p belongs to the GTPase family, same as the translation release factor eRF3. 
Dom34p is homologous to eRF1, another release factor which structurally resembles 
tRNA.  In NGD, endonucleolytic cleavage of mRNAs is triggered. However, the 
identity of endonuclease remains unknown in this decay pathway.  
In summary, in the mRNA surveillance systems mentioned above, translation is 
always required to discriminate aberrant transcripts from normal ones. Defects in 
translation elongation or termination lead to the interaction between the ribosome and 
the surveillance complex, which will result in the recruitment of the general mRNA 
decay machinery to degrade the defective transcripts.  
 
1.1.5 cis-trans interaction affecting mRNA stability 
Cis-elements are sequences in mRNA that regulate its stability in response to 
stimuli or cellular signals. They are mostly located in the 3’-UTR and serve as 
binding sites for trans-factors. Trans-factors are usually RNA binding proteins and 
the cis-trans interaction determines the stability of specific mRNA.  
AU-rich elements (AREs) are the prevailing instability 3’UTR cis-elements in 
various short-lived mRNAs such as the growth factors, cytokines and lymphokines.  
AREs are 50 to 150 nucleotides in size and generally contain multiple copies of the 
AUUUA motif. Interaction between AREs and specific regulation elements modulates 
the half-lives of ARE-containing transcripts (Chen & Shyu., 1995).  
The protein tristetraprolin (TTP) is one of the destabilizing elements for ARE-
containing mRNAs. It specifically binds to AREs via a zinc-finger domain and also 
interacts with decay enzymes through an activation domain to degrade ARE-
containing mRNA. ARE-mediated mRNA decay (AMD) is initiated by deadenylation 
followed by 3’-5’ or 5’-3’ decay pathway (Mukherjee et al., 2002; Lykke-Andersen 
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and Wagner, 2005). HuR is another ARE-binding protein but plays an antagonizing 
role. It binds to ARE and poly(A) regions of target mRNA and prevents it from 
degradation (Brennan and Steitz, 2001).  
In addition to the ARE-binding proteins, another class of element, microRNA 
(miRNA), is recently suggested to recognize ARE and regulates mRNA stability (Jing 
et al., 2005). One microRNA, mir16, is required for specific degradation of tumor 
nercosis factor-α (TNF-α) mRNA, by base-paring with the ARE in the 3’ UTR. Both 
double-stranded ribonuclease Dicer and ARE-binding protein TTP are required for 
this TNF-α mRNA turnover.  
 
1.1.6 mRNA degradation and diseases 
Modulating mRNA stability is crucial for maintaining the normal function of the 
cell and the organism as a whole. Dysregulation of mRNA stability, being either 
failure in removing aberrant mRNAs or disrupted cis-trans interaction, is associated 
with many human diseases ( Frischmeyer and Dietz, 1999; Hollams et al., 2002).  
For example, β-thalassemia is caused by mutations in the β-globin gene, which 
usually generates a premature stop codon in the first two exons and leads to the 
production of truncated proteins. The reduced level of mutant transcripts and proteins 
gives heterozygous individuals a mild syndrome, while a higher level of mutant 
transcripts causes severe phenotype.  Mutations occur in the last exon of the β-globin 
gene can escape the NMD surveillance system and produce dominant negative protein. 
The truncated α/β dimer jams the proteolysis system and contributes to the typical 
clinical syndrome.  
Many diseases are related to AREs as well. AREs are found in many cytokines 
and growth factors and act as destabilizing elements. In several types of tumor cells, 
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the ARE critical for c-myc stability is lost due to mutation or deletion, rendering the 
mRNA more stability than the wild-type one. In α-thalassemia, certain variant causes 
a translation read-through and the displacement of the stabilizing factor bound to the 
3’ARE.  This is associated with a decrease in the mRNA level and hence the 
development of the disease. 
 
1.2 mRNA 5’ decay machinery and processing bodies 
The machinery of the 5’ decay pathway is composed of multiple proteins co-
localizing to the processing bodies (P-bodies) in the cytoplasm. P-bodies are also the 
site for other RNA degradation events such as RNA interference (RNAi) and NMD. 
The balance of mRNAs between the translation and decay states is essential for gene 
regulation and adaptation to environmental changes.   
 
1.2.1 Components of mRNA 5’ decay machinery  
The proteins involved in the mRNA 5’ decay pathway aggregate to form the 5’ 
decay machinery, including the factors in RNA binding, RNA remodeling, complex 
scaffolding and catalysis. The composition of the 5’ decay complex is best studied in 
yeast on which the following introduction is primarily based, as shown in Figure 4.   
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 Figure 4. S. cerevisiae 5’ decay complex.  Budding yeast 5’ decay complex are 
composed of 5’-3’ exonuclease Xrn1p, decapping enzyme Dcp2p/Dcp1p, DEAD-
box helicase Dhh1p, Lsm1-7, Edc3p and other auxiliary RNA-binding proteins 
Figure is modified from Coller and Parker, 2004. 
Dcp1p/Dcp2p) Decapping enzyme complex are composed of two subunits: the 
regulatory unit Dcp1p and the catalytic unit Dcp2p. The features of these two proteins 
will be addressed in Chapter 1.3. 
Dhh1p is a DEAD-box RNA helicase of 58 kDa that actively represses translation 
and stimulates the assembly of the decapping machinery. Dhh1p also directly 
activates the decapping enzyme Dcp2p in the in vitro assay, maybe by facilitating 
RNA binding and removing the RNA secondary structure (Coller and Parker, 2005; 
Coller et al., 2001; Cheng et al., 2005; Fischer and Weis, 2002). Homologs of the 
Dhh1 protein are found in other organisms and participate in a wide range of 
developmental phenomena consistent with its function in translation repression and 
mRNP formation (Navarro et al., 2001; Nakamura et al., 2001; Ladomery et al., 1997). 
 Pat1p is an 88-kDa protein with unknown biochemical function. Similar to 
Dhh1p, Pat1p actively represses translation and stimulates the assembly of the 
decapping machinery. Interestingly, Dhh1p and Pat1p also interact with the 
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deadenylase or poly(A) binding protein from the 3’ end, indicating a role for 
coordinating the deadenylation and decapping steps of mRNA decay (Bonnerot et al., 
2000; Coller and Parker, 2005; Coller et al., 2001).  
Lsm1-7p.  Sm-like (Lsm) proteins are small RNA binding proteins of 8-28 kDa 
that share a common Sm domain. Different subsets of Lsm proteins are observed in 
targeting specific substrates, such as rRNA, nuclear RNA or mRNA (Kufel et al., 
2002; Kufel et al., 2003; Tharun et al., 2000). The hetero heptameric complex 
containing Lsm1-7p is an essential component of the decapping machinery, while 
Lsm2-8p complex which largely overlaps with Lsm1-7p is engaged in the pre-mRNA 
splicing in nucleus. The Lsm1-7p complex functions downstream of deadenylation 
event and protects the 3’ RNA termini (He and Parker, 2001). The link between 
Lsm1-7p with Pat1p and Dcp1p suggests that Lsm1-7p play a role in nucleating the 
decapping complex and promote decapping (Bouveret et al., 2000; Tharun et al., 2000; 
Tharun et al., 2005).  
Edc1p and Edc2p are two small RNA binding proteins as decapping enhancers 
(Dunckley et al., 2001; Schwartz et al., 2003). Edc1p and Edc2p are homologous 
proteins and possess RNA binding capacity. They both interact with the decapping 
enzyme and probably enhance decapping efficiency by facilitating RNA association 
(Steiger et al., 2003). Edc1p and Edc2p are specific in yeast, without homologs in 
other species.  
 Edc3p, also called Dcp3p, is another decapping enhancer which shares no 
sequence homology with Edc1p and Edc2p (Kshirsagar and Parker, 2004). Edc3p is 
not essential for mRNA decapping in vivo, but it can stimulate the decapping 
efficiency. It contains a Sm-like domain in the N-terminus and two conserved but 
functionally unidentified domains in the C-terminus (Albrecht and Lengauer, 2004; 
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Anantharaman and Aravind, 2004). Edc3p physically interacts with Dhh1p and Dcp2p, 
implying a central role for Edc3p in the decapping complex assembly (Parker et al. 
unpublished]. Consistently, human Edc3 also co-immunoprecipitates with hDcp1a 
and Rck/p54 (Dhh1 homolog in human) (Fenger-GrØn et al., 2005).  Interestingly, in 
addition to being a general decay factor, Edc3 can also specifically modulate the 
stability of the mRNA of the ribosome protein Rps28b in a deadenylation-
independent manner.  Rps28b is found to bind to a stem-loop structure of its own 
mRNA and recruits the decapping machinery via interaction with Edc3 protein (Badis 
et al., 2004).  
Xrn1p is a 5’-3’ exonuclease that digests mRNA with the 5’ terminus exposed. 
The XRN1 gene is essential in 5’-3’ mRNA hydrolysis as its deletion leads to 
accumulation of deadenylated but uncapped mRNAs in yeast (Hsu and Stevens, 1993; 
Muhlrad et al., 1994). Xrn1p shares homology with other 5’-3’ exonucleases, 
however the atomic structure of Xrn1 protein is currently unavailable (Solinger et al., 
1999).  
 
1.2.2 mRNA cytoplasmic processing bodies  
The 5’ decay pathway enzymes and cofactors are enriched in the cytoplasmic loci 
called processing bodies (P-bodies), where normal transcripts are committed for 
decapping and decay.   Other RNA molecules are also brought to P-bodies for 
degradation, such as the PTC-containing mRNAs in the NMD pathway and the 
targeted mRNAs in RNAi.  
P-bodies and 5’ decay. Intensive genetic and physical interactions have been 
reported on the 5’ decay factors. Consistently, these factors are found to co-localize in 
specific foci of the cytoplasm, called mRNA processing bodies. The first evidence of 
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compartmentation of the 5’ mRNA decay complex comes from the observation that 
human decapping enzymes reside in discrete cytoplasmic loci and co-localize with 
Xrn1 and the Lsm1-7 complex (Ingelfinger et al., 2002; van Dijk et al., 2002). A 
broader investigation in yeast reveals that in addition to the 5’ decay factors Dcp1p, 
Dcp2p, Xrn1p and Lsm1p, other proteins engaged in translation termination and 
mRNA remodeling such as Dhh1p and Pat1p are also found to concentrate in these 
foci, designated processing bodies (Sheth and Parker, 2003).  In contrast, there is no 
specific locus for the 3’ decay pathway, and the exosome and Ski proteins are evenly 
distributed in the cytosol. 
In higher eukaryotes, extra components that have no yeast counterparts are 
identified in P-bodies. One of them is Ge-1, or Hedls. Ge-1 stimulates hDcp2 
decapping activity and is suggested to mediate the hDcp1a and hDcp2 protein 
complex formation as well (Fenger-GrØn et al., 2005). Another protein is GW182, an 
182 kDa RNA-binding protein characterized by multiple glycine(G)-trptophan(W) 
repeats. GW182 proteins are located in the cytoplasmic speckles coinciding with 
mRNA 5’ decay factors (Eystathioy et al., 2003). These proteins reflect the 
complexity of P-bodies composition and function in higher eukaryotes. 
P-bodies and NMD. The mRNA surveillance system is related to P-bodies as 
well. Two proteins of the metazoan NMD complex, SMG7 and SMG5, are located in 
the P-bodies and are capable of recruiting the phosphorylated key NMD factor Upf1 
via their 14-3-3 like domains (Unterholzner et al., 2004; Fukuhara et al., 2005).  Upf1 
further interacts with proteins in the 5’ decay pathway, especially Dcp2, mediating 
PTC-containing transcripts for degradation (Lejeune et al., 2003). 
P-bodies and RNAi. It was recently discovered that RNAi also occurs in the 
cytoplasmic processing bodies.  RNAi involves specific digestion or translation 
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repression of target mRNAs, which is carried out by two types of small RNAs: siRNA 
and miRNA respectively. Both small RNAs are assembled into the functional RNP 
called RNA-induced silencing complex (RISC). In C. elegans and mammalian cells, 
the Argonaut protein Ago2, which is the signature component of RISC, physically 
interacts with the P-bodies protein GW182 to mediate RISC localization.  miRNA and 
its target mRNA accumulate in P-bodies for translation repression, while siRNA-
mediated RNAs are delivered to P-bodies for degradation (Sen and Blau, 2005; Liu et 
al., 2005a; Liu et al., 2005b; Ding et al., 2005, Pillai et al., 2005, Jakymiw et al., 
2005).   
P-bodies dynamics. Since mRNA translation and degradation are inversely 
related, the balance between pools of mRNAs in active translation or degradation 
stages modulates the size and abundance of P-bodies. Not all mRNAs in the P-bodies 
are committed to degradation; mRNAs can also be transiently stored in the P-bodies 
and exit P-bodies to resume translation, especially when environmental stress is 
encountered (Sheth and Parker, 2003, Teixeira et al., 2005; Brengues et al., 2005). 
The influx of mRNA is required for the assembly of P-bodies but the process of P-
bodies formation is largely obscure. It is proposed that proteins such as Dhh1, Pat1, 
Ge-1 and GW182 play a central role in maintaining P-body stability, since knocking 
down these genes eliminates the P-body. On the contrary, the decapping enzyme 
Dcp2 acts downstream of the P-body assembly, because reducing protein expression 
does not prevent P-body formation (Yang et al., 2004; Coller and Parker, 2005, Yu et 
al., 2005).  
P-bodies and disease. Primary biliary cirrhosis (PBC) is an autoimmune disease 
that results in hepatic fibrosis and liver failure. PBC patients are found to develop 
autoantibodies directed against subcellular structures, including P-bodies. A subgroup 
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of PBC patients are found to produce antibodies reacting with P-body components 
Ge-1 and GW182 to show a specific cytoplamic staining pattern (Yu et al., 2005).  
 
Sequestering mRNAs for destruction or storage in discrete loci such as P-bodies 
have several potential benefits. Firstly, by confining the decay enzymes in the P-
bodies, it prevents the premature degradation of functional mRNAs. Secondly, the 
decay enzymes and accessory factors are co-localized and concentrated, which will 
enhance the efficiency of regulation and enzymatic activity. Thirdly, by shuttling 
mRNAs between translationally active and repressed states, cells can quickly adapt to 
stress conditions and resume normal function when the environment turns favorable.  
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1.3 mRNA decapping enzymes 
mRNA decapping is a critical step in the 5’ decay pathway and the reaction is 
carried out by the decapping enzyme Dcp2, assisted by Dcp1. Dcp2 is a 
pyrophosphatase while Dcp1 stimulates its activity to form a functional holoenzyme.  
 
1.3.1 Characteristics of Dcp1 protein 
The DCP1 gene was first cloned from S. cerevisiae and was implicated to be a 
decapper (Beelman et al., 1996).  Several lines of evidence suggest that Dcp1p is 
highly important in mRNA decapping.  Firstly, the dcp1Δ strain is slow in growth and 
accumulates deadenylated but capped mRNA. Secondly, cell extract purified from the 
dcp1Δ strain lacks the decapping activity. Thirdly, overexpression of Dcp1p leads to 
increased mRNA decapping. Finally, isolation of epitope-tagged Dcp1p contains 
decapping activity.  Similar phenotype is observed in fission yeast, in which the 
deletion of the SpDCP1 gene strongly affects cell growth and mRNA degradation 
(Sakuno et al., 2004). It was discovered later that Dcp1p is not an active enzyme per 
se that directly catalyzes cap hydrolysis, and previously observed activity might be 
contributed by the co-purified Dcp2p contaminant. Nevertheless, Dcp1p is still an 
essential component of the decapping machinery. 
Dcp1 proteins from different organisms vary greatly in length and share a 
moderate degree of sequence homology only in the N-terminus (Figure 5). The yeast 
proteins are the shortest, containing the single N-terminal conserved region, while the 
metazoan proteins have long extension in the C-terminus. No recognizable domain 
was detected at first by conventional sequence analysis tools for Dcp1 proteins. 
However, by incorporating a two-dimensional hydrophobic cluster analysis, it is 
predicted that the first 100 amino acids of one of two human Dcp1 homologs,  
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hDcp1a, (also called SMIF for smad-4 interacting factor) belongs to the EVH1 
domain family,  despite the low sequence identity between hDcp1a and EVH1 
proteins (Callebaut, 2002). The structural implication of the C-terminal region of 
metazoan Dcp1 proteins is currently limited. 
Dcp1p interacts with Dcp2p in various organisms. For example, the Dcp1 protein 
co-immunoprecipitates with the Dcp2 protein in cell extracts in budding yeast, fission 
yeast and mammalian systems (Dunckley and Parker, 1999; Lykke-Andersen, 2002; 
Sakuno et al., 2004); moreover, Dcp1 and Dcp2 are co-localized in the P-bodies in 
close proximity (Cougot et al., 2004a; Ingelfinger et al., 2002; Sheth and Parker, 
2003). By binding to Dcp2p, S.cerevisiae Dcp1p can greatly stimulate the decapping 
activity of Dcp2p in an in vitro assay (Dunckley and Parker, 1999; Steiger et al., 
2003). However, the stimulation effect is not observed in the C.elegans and human 
homologs (Lall et al., 2005; Lykke-Andersen, 2002). The discrepancy is partly 
explained by the discovery that in human, theGe-1 (also called Hedls) protein 
mediates the interaction of the hDcp1a and hDcp2 proteins (Fenger-GrØn et al., 2005; 
Simon et al., 2006).  
The Dcp1 protein has multiple functions in addition to mRNA decapping. 1) 
Yeast Dcp1p interacts with the translation initiation factor eIF4G, the poly(A)-binding 
protein Pab1p and the translation termination protein eRF3, which suggests that 
Dcp1p may also involve in remodeling mRNA from the translation to the destruction 
status (Kofuji et al., 2006; Vilela et al., 2000). 2) The human Dcp1 protein plays a 
role in the transforming growth factor-β (TGF-β) signaling pathway (Bai et al., 2002). 
One of the two homologous proteins in human, hDcp1a, is reported to interact with 
the Smad4 protein and activate gene transcription. 3) In C. elegans, the Dcp1 protein 
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is part of the osk RNP and is essential in mediating the posterior localization of osk 













Figure5. Schematic diagram of Dcp1 proteins Domain organization of 
S.cerevisiae Dcp1p, S. pombe Dcp1p, D. melanogaster Dcp1, H. sapiens Dcp1a 
and Dcp1b respectively. The conserved N-terminal regions among all Dcp1 
proteins are shown in solid black color and the C-terminal regions shared by 
higher eukaryotes are shown in grey lines. Non-coneserved regions are shown in 
white. The number of amino acids of the individual protein is labeled. 
 
1.3.1.2 The EVH1 domain 
Sequence analysis suggested that hDcp1a may adopt a folding similar to EVH1 
domain (Callebaut 2002). EVH1, or Enabled/VASP homology 1, domain is one of the 
common modules that recognize proline-rich sequences (PRSs) and belongs to the 
superfamily of the Pleckstrin homology (PH) domain (Ball et al., 2002; Zarrinpar et 
al., 2003). EVH1 domain-containing proteins are widely distributed and highly 
diverse in function, with more than twenty members are estimated in human and 
typically play a role in recruitment or targeting. Usually, the PRS binding to EVH1 
domain is highly specific but of low affinity. According to the consensus sequences 
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recognized, EVH1 domains can be classified into several classes represented by the 
following proteins: Ena/VASP, Wiskott-Aldrich syndrome protein (WASP), Homer-
Vesl proteins and Sprouty/Spred proteins.  
The Ena/VASP family proteins are involved in actin polymerization by targeting 
adhesion proteins such as vinculin, zyxin and the listerial ActA protein. The EVH1 
domains of this family recognize the FPxΦP (x is any residue and Φ is hydrophobic 
residue) motifs in their targets. The WASP family proteins are also associated with 
cytoskeleton regulation, interacting with the actin binding protein WASP interacting 
protein, WIP.  A minimal 25 amino acids peptide containing the DLPPPEP motif 
found in WIP is required for interaction with WASP.  The Homer/Vesl family 
proteins are involved in synaptic signaling, binding to metabotropic glutamate 
receptors, inositol-1,4,5-trisphosphate receptors, ryanodine receptors and the Shank 
family proteins. The PRS motif recognized by the Homer/Vesl family is PPxxF. The 
Spred/Sprouty family proteins are modulators in receptor tyrosine kinase signaling 
and the target of the EVH1 domain of this family is yet to be identified (Ball et al., 
2002; Zarrinpar et al., 2003). 
The EVH1 domain consists of about 110 residues and the overall structure from 
the four classes of EVH1 domains all consists of concave antiparallel β-sandwich with 
a C-terminal α helix (Figure 12). The core structures are highly similar, with insertion 
or deletion in the peripheral loop region.  In all EVH1 domains, a conserved patch 
consists of several aromatic residues forms the PRS binding site.  The PRS ligands 
adopt a left-handed PPII helix and the pyrrolidine rings of the proline residues on one 
edge of the PPII prism make contact with the conserved aromatic patch.  The ligand 
orientation and specificity are determined by those residues in the vicinity of 
conserved patch in the case of Homer and Ena/VASP; or by the extended peptide 
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binding surface on the other side of the EVH1 domain in the N-WASP/WIP complex 
(Volkman et al., 2002, Ball et al., 2000; Beneken et al., 2000; Fedorov et al., 1999).  
 
1.3.2 Characteristics of Dcp2 protein  
The S. cerevisiae DCP2 gene was first identified as a high-copy suppressor of the 
dcp1-2 mutant, a strain that is defected in both the general mRNA 5’ decay and NMD 
at non-permissive temperature (Dunckley and Parker, 1999). The overexpression of 
Dcp2p can rescue the mRNA degradation defect in the dcp1-2 strain, indicating that 
Dcp2p plays an important role in the 5’ decay pathway.  The human Dcp2 gene is 
later identified and the purified protein exhibits robust decapping activity in the in 
vitro assay, confirming that Dcp2 protein is the de facto mRNA decapping enzyme 
(Lykke-Andersen, 2002; van Dijk et al., 2002; Wang et al., 2002b).   
The lengths of the Dcp2 protein sequences are highly variable in different species; 
however the N-terminal region of about 300 amino acids is conserved (Figure 6).  In 
yeast, a C-terminal truncation containing first 300 residues is sufficient to rescue the 
dcp2Δ phenotype (Dunckley & Parker, 1999). The Dcp2 N-terminus contains the 
consensus Nudix motif, a signature found in a class of pyrophosphatase. The 
predicted Nudix domain is flanked by two additionally conserved regions termed Box 
A and Box B. The C-terminus of the Dcp2 proteins are less conserved and are of 
various lengths (Wang et al., 2002b).  
Biochemical analysis carried out on the recombinant human or yeast Dcp2 
proteins shows not only characteristics that are consistent with Dcp2 as a Nudix 
hydrolase, but also other unique features as a specialized mRNA decapping enzyme 
( Piccirillo et al., 2003, Steiger et al., 2003, LaGrandeur and Parker, 1998): 
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1) Dcp2 is the mRNA decapping enzyme, belonging to the Nudix hydrolase family. 
 
Nudix hydrolase + Mg2+
XpppY                                      Xpp  + pY 
Dcp2 +  Mg2+
m7Gppp-RNA                                       m7Gpp  +  p-RNA 
The Nudix motif is the active site, as the substitution of one or more key glutamic 
acid residues in the consensus sequence abolishes the Dcp2 decapping activity. 
Similar to other Nudix enzymes, Dcp2 depends on the divalent cation Mg2+ for 
activity and Mn2+ can greatly enhance the enzyme activity (Piccirillo et al., 2003).  
2) Dcp2 specifically hydrolyzes capped-mRNA but not a cap structure lacking 
RNA moiety, since the addition of the cap analog m7GpppG does not inhibit the 
decapping activity, as in contrast to the scavenger decapping enzyme DcpS (Piccirillo 
et al., 2003; Liu et al., 2002; Wang and Kiledjian, 2001). 
3) Uncapped mRNA can inhibit decapping, indicating that Dcp2 is an RNA 
binding protein. Evidence also comes from north-western detection, in which labeled 
RNA has been retained with the Dcp2 protein on gel. The deletion of the C-terminal 
region, containing Box B, in the hDcp2 protein abolishes the RNA binding capacity 
of protein truncated. So the Box B region is suggested to be the site for RNA 
recognition (Piccirillo et al., 2003).  
4) RNA binding is the prerequisite for decapping. No UV cross-linking of the cap 
analog to Dcp2 is observed and the cap structure crosslinks to Dcp2 only when it is 
attached to an RNA moiety (Piccirillo et al., 2003). 
5) Dcp2 prefers longer mRNA as its substrate, and efficient decapping occurs 
when the RNA is longer than 25 nucleotides in yeast. In the case of the more robust 
human Dcp2 enzyme, an RNA substrate as short as 9 nucleotides is able to be poorly 
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decapped (van Dijk et al., 2002).  In both yeast and human Dcp2 proteins, the 
efficiency of decapping is in correlation with the length of the substrate. It is 
hypothesized that the special separation of the RNA binding site and the decapping 
active site accounts for the dependence on the substrate length. 
6) Although the guanosine cap of eukaryotic mRNA is mono-methylated, tri-
methylated cap structure can also be hydrolyzed by Dcp2, which means Dcp2 has no 
discrimination against mRNA cap methylations (Cohen et al., 2005). 
The activity of the Dcp2 protein is subjected to regulations. On one hand, Dcp2 is 
stimulated by the 5’ decay factors co-localized in P-bodies, including Dcp1, Edc1, 
Edc2, Edc3, Lsm1-7 complex and Dhh1, which is in agreement with their common 
function in mRNA turnover (Coller & Parker, 2004). On the other hand, Dcp2 activity 
is antagonized by factors that promote mRNA stability.  For example, the poly(A) tail 
association protein PABP and cap-binding protein eIF4E can inhibit Dcp2 decapping 
directly (Khanna & Kiledjian, 2004). Another decapping inhibitor, VCX-A, also 
possesses the capacity to bind capped mRNA, therefore negatively regulates Dcp2 
and stabilizes mRNA in cells. The inhibitory effect of VCX-A is possibly related to 
the X-linked nonspecific mental retardation (Jiao et al., 2006). 
  
1.3.2.1 The Nudix hydrolases 
The Nudix hydrolases catalyze the hydrolysis of nucleoside diphosphates linked to 
other moieties, X, and are widely distributed across species, including viruses, 
bacteria, archaea and eukaryotes. The Nudix hydrolases are characterized by a 
consensus 23-residue sequence of GX5EX7REUXEEXGU termed the Nudix motif 
(U is a bulky residue and X is any residue), which is the Mg2+ binding site and the  
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Figure 6. Schematic diagram of Dcp2 proteins.  a) The sequence alignment of 
various Nudix motif-containing proteins with the consevered residues shown in 
bold letters. Figure is adapted from Bessman et al. 2006. b).The conserved regions 
among Dcp2 proteins from different species reside in the N-terminal portion, 
which is further divided into a central Nudix fold flanked by the Box A and Box B 
regions. The C-terminal regions are non-conserved. Figure is adapted from Wang 
et al. 2002b. 




catalytic center. The Nudix families are highly versatile as their substrates can be 
oxidized nucleoside triphosphates, nucleotide-sugars, dinucleoside polyphosphates, 
dinucleotide coenzymes, or capped mRNA. By hydrolyzing these compounds, the 
Nudix enzymes play the protective or regulatory role in cell metabolism (Bessman et 
al., 1996; Mildvan et al., 2005). 
The catalytic mechanisms of Nudix proteins are diverse in regard to the position 
of nucleophilic substitution and the number of divalent cations required. Generally, 
hydrolysis is catalyzed via the nucleophilic substitution by water at the specific 
phosphorus atom. In the case of GDP-mannose hydrolase, the nucleophilic attack 
occurs at a carbon atom instead. Divalent cation such as Mg2+ or Mn2+ are usually 
required for activity, although the number of cations rangeing from two in the ADP-
ribose pyrophosphatase to three in the Ap4A pyrophophatase (Bailey et al., 2002, 
Gabelli et al., 2001).  
Several structures of the Nudix hydrolases have been determined and they all 
share the common feature of an α/β/α sandwich called the Nudix fold.  Generally the 
clusters of glutamic residues in the Nudix motif are involved in cation coordination, 
with one of them serving as the base for nucleophilic attack. In contrast to the 
relatively conserved catalytic mechanism, the versatility and specificity in substrate 
recognition is achieved by variable loop regions around Nudix fold and/or N-terminal 
extension (Bessman et al., 1996; Mildvan et al., 2005).  
 
1.3.3 Other decapping enzymes 
In addition to Dcp2, there are several enzymes that harbor the cap degradation 
activity, including the scavenger decapping protein DcpS, nuclear decapping protein 
X29 and virus protein L-A gag. Despite of the common capacity to remove the 
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mRNA 5’ cap, the three decapping enzymes are diverse in their cellular functions, 
atomic structures and catalytic mechanisms.  
Scavenger decapping enzyme DcpS 
In the 3’ exonucleolytic mRNA decay pathway, the processive exosome degrades 
the transcript body, leaving the m7GpppN as its product. The residual cap without the 
RNA moiety must be removed to prevent blocking the cap binding complex. And this 
scavenger decapping activity is carried out by DcpS to hydrolyze the residual cap and 
complete the 3’ mRNA degradation. Different from Dcp2, which produces m7GDP, 
DcpS hydrolyzes m7GpppN to release m7GMP as a by-product. Moreover, the 
m7GDP released by Dcp2 in the 5’decay pathway is converted by DcpS to m7GMP 
(Liu et al., 2002; Wang and Kiledjian, 2001).    
DcpS belongs to the histidine triad (HIT) pyrophosphatase superfamily, which is a 
group of nucleotide binding proteins that hydrolyze the pyrophosphate bonds. The 
conserved His-Φ-His-Φ-His-Φ triad (Φ denotes hydrophobic residue) is critical for 
catalysis as the substitution of the central histidine eliminates DcpS decapping activity 
(Liu et al., 2004). DcpS forms homodimer in solution and the dimeric complex is the 
functional unit. Each monomer is composed of two distinct domains: the N-terminal 
domains dimerize in a domain-swap mode and the C-terminal domains contain the 
HIT motifs (Figure 7a). In the substrate-free state, each DcpS monomer adopts the 
symmetric conformation; in the binary complex with cap analog, two monomers 
exhibit closed and open forms respectively. The substrate is catalyzed in the closed 





Nuclear decapping enzyme X29 
Similar to mRNA, small nuclear RNA (snRNA) is also transcribed by RNA 
polymerase II and co-transcriptionally capped, except that snRNA is tri-methylated in 
the 2, 2, 7- position of guanosine.  The cap structure of snRNA is important for its 
stability and proper localization (Cougot et al., 2004b). A 25 kDa protein in Xenopus 
laevis, X29, specifically binds to U8 small nucleolar RNA (snoRNA) in the nucleous 
and negatively regulates U8 stability by cleaving the 5’ cap (Ghosh et al., 2004). X29 
belongs to the Nudix enzyme family and cleaves the di-phosphate bond of snRNA or 
mRNA 5’ cap in the metal-dependent manner.  
The structure of X29 shows that the functional unit is formed by two identical 
monomers. Each molecule contains a dimerizing N-terminal domain and a canonical 
Nudix domain (Figure 7b).  And the structure of the X29- m7GpppA complex shows 
that the adenine base of the cap analog is stacked in the active site and the 
triphosphate group is positioned close to the catalytic glutamates, coordinated by three 
Mn2+ ions (Scarsdale et al., 2006). The substrate recognition of X29 is also inferred 
from its unique dipolar dimer surface and subtle changes upon holoenzyme formation. 
  
Virus decapping enzyme L-A gag 
Viruses develop strategies targeting the mRNA 5’ cap to prevent viral mRNA 
degradation and increase translation efficiency. Some viruses utilize the host 
transcription machinery for producing capped viral mRNA. Others carry their own 
RNA capping enzymes, or bypass the need for capped mRNA with the internal 
ribosome entry site (IRES). The approach of the L-A virus is indirect. Its coat protein 
Gag harbors decapping activity against host mRNAs, leading to the saturation of host 
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mRNA degradation machinery. Thus the half-life of virus mRNA is extended and the 
production of virual proteins is increased (Cougot et al., 2004b). 
The L-A Gag protein evolves enzymatic activity to remove the cap from host 
mRNAs and covalently attaches the m7GMP moiety to residue His154. His154 resides 
in a stretch formed by three loops (Figure 7c). It is proposed that the positively-
charged residues in the stretch interact with mRNA and reorient the m7GTP cap 
correctly in the catalytic center (Tang et al., 2005; Naitow et al., 2002).  
Figure 7. Structures of RNA decapping enzymes.  a) The crystal structure of 
human scavenger decapping enzyme DcpS complexed with m7GpppG (1STO). 
The dimeric enzyme exhibits closed and open conformations simultaneously b) 
The dmeric Xenopus nuclear U8 snoRNA decapping enzyme X29 in complex with 
m7GTP (2A8R). c) Ribbon diagram of the structure of L-A virus Gag protein 
(1M1C). The regions with higher flexibility are shown in red. The decapping 
active site resides in a trench formed by loops. The figure 7b is modified from its 
original publication. 
a b c 
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1.4  Rationales of this study 
The accumulation of knowledge on mRNA decay in the recent years has provided 
important insights into the function and regulation of the decapping proteins Dcp1 and 
Dcp2.  Yet several questions still remain open regarding the decapping complex:  
1) What is the structure of the Dcp1 protein and is the prediction of the EVH1 
domain correct?  If yes, how is Dcp1 related to other EVH1 members?  
2) What is the structure and decapping mechanism of Dcp2 compared with other 
Nudix hydrolases? 
3) How does yeast Dcp1p interact with Dcp2p? Given the divergence in terms of  
the decapping complex formation between lower and higher eukaryotes, is there a 
structural basis for this observation?  And how is the stimulation effect of Dcp1p on 
Dcp2p achieved?  
4) Dcp1 and Dcp2 are part of a large 5’ decay complex and factors such as Dhh1p 
and Edc3p have been reported to associate with and regulate the decapping complex.  
So how does the Dcp1-Dcp2 complex interplay with other 5’ decay components to 
form the functional RNA-protein complex? 
In order to answer the above questions, the structures of the yeast decapping 
enzyme Dcp1 and Dcp2 in both free and complex forms have been determined by X-
ray crystallography. Subsequently, the results were analyzed to understand the 
properties of these molecules and to assign functions to critical residues. In vivo and 
in vitro experiments performed in our and collaborator’s labs were in good agreement 
with our hypothesis. The structural study not only enriches our understanding on 
mRNA decapping and but also lays a starting foundation for further study on mRNA 
degradation and regulation. 
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Chapter2.  Materials and Methods 
 
2.1 Experimental materials  
2.1.1 Strains 
E.coli BL21 star (DE3)   Invitrogen 
E.coli DH5α    Invitrogen 
 
2.1.2 Media 
LB   5 g Bacto-yeast extract, 10 g Bacto-trypton, 10 g NaCl (1L) 
LB agar  liquid LB medium supplemented with 1.5% Agar 
YPUAD 2% glucose, 2% peptone, 1% yeast extract, 40 µg/ml uracil, 40 
µg/ml adenine, and 40 µg/ml tryptophan 
YES 5g/l yeast extract, 30g/l glucose, 225 mg/l adenine, histidine, 
leucine, uracil and lysine hydrochloride 
 
2.1.3 Vector 
pGEX-6p-1   Amersham Biosciences 
 
2.1.4. Oligonucleotides
Oligonucleotides were ordered from Proligo and Research Biolabs.  






BamHI-spDCP2-1-F  CGGGATCCATGTCGTTCACAAATGCCACG 
BamHI-spDCP2-96-F  GCGGATCCATTCCTGTCCGCGGAGCTATAATG 









































































Pfu DNA polymerase    Stratagene 
PreScission protease   Amersham Biosciences 
Capping enzyme   (self-prepared, Chapter 2.3.5) 
 
2.1.6 Kits 
DNeasy Tissue Kit     QIAGEN 
RNeasy Mini Kit     QIAGEN 
ProSTAR Ultra HF RT-PCR system   Stratagen 
QIAprep spin Miniprep Kit    QIAGEN 
QIAquick Gel Extraction Kit    QIAGEN 
QIAquick PCR purification Kit   QIAGEN 
Coomassie Protein Assay Kit    PIERCE 
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Site-Directed Mutagenesis Kit   QIAGEN 
AmpliScribe High Yield Transcription Kit  EPICENTRE 
 
2.2.7 Chromatography Columns 
Glutathione Sepharose 4B 
HiPrep Desalting Column 
Hiload Superdex-75 26/60 
Hiload Superdex-200 26/60 
MonoQ 10/30 
MonoS  10/30 
All Columns were purchased from GE Healthcare. 
 
2.1.8 Crystallization kits and tools 
Crystal Screen 1   Hampton Research 
Crystal Screen 2   Hampton Research 
NATRIX    Hampton Research 
PEG/ION    Hampton Research 
ADDITIVE SCREEN   Hampton Research 
HEAVY ATOM SCREEN  Hampton Research 
Wizard I    Emerald Biostructures 
Wizard II    Emerald Biostructures 
Crystallization tools   Hampton Research 
 
2.1.9  Buffers 
DNA and Protein Electrophoresis 
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DNA electrophoresis Buffer 40 mM Tris, 1.14% acetic acid, 1mM ethylene 
diamine tetra acetic acid (EDTA) 
SDS-PAGE running Buffer 25 mM Tris base, 192 mM glycine, 0.1% (w/v) 
sodium dodecyl sulfate (SDS) 
SDS-PAGE Staining Buffer 0.025% Coomassie Brilliant Blue R-250 30% 
Methanol, 10% Acetic Acid 
SDS-PAGE Distaining Buffer 30% Methanol, 10% Acetic Acid 
 
Protein Purification 
Cell Lysis Buffer   20 mM Tris-HCl, pH 7.8, 500 mM NaCl, 2mM 
EDTA, 2mM benzamidine, 0.1 mM 
phenylmethanesulfonyl fluoride (PMSF), 2mM  
dithiothreitol (DTT) 
Elution Buffer 20 mM Tris-HCl, 500 mM NaCl, 2mM EDTA, 
2mM Benzamidine, 0.1 mM PMSF, 2mM DTT, 
20 mM reduced Glutathione, pH 7.8 
MonoS Buffer A 20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 2mM 
DTT 
MonoS Buffer B   20 mM Tris-HCl, pH 8.0, 1 M NaCl, 2mM DTT 
MonoQ Buffer A   20 mM MES pH6.5, 150 mM NaCl, 2mM DTT 




Capping buffer (15×) 750 mM Tris HCl pH 7.8, 90 mM KCl, 37.5 
mM DTT, 18.75 mM MgCl2, 1.5 mg/ml BSA
  
Decapping buffer (9X) 450 mM Tris-HCl, pH7.9, 270 mM (NH4)2SO4, 
9 mM MgCl2   
 
2.1.10 Chemicals 
100 bp DNA ladders    New England Biolabs 
1 kb DNA ladders    New England Biolabs 
2-log DNA ladders    New England Biolabs 
Prestained protein markers   New England Biolabs 
m7GpppG     Epicentre 
α-32P GTP      Amersham 
γ-32P adenosine triphosphate (ATP)  Perkin Elmer 
IPTG      Invitrogen 
30% Acrylamide/Bis solution (29:1)  Bio-Rad 
2-Methyl-2, 4-pentanediol (MPD)  Hampton Research 
Polyethylene Glycol 400   Hampton Research 
Polyethylene Glycol 3350   Hampton Research 
Ethylene Glycol (EG)    Hampton Research 
Trimethyl lead acetate (TMLA)  Hampton Research 
Nuclease-free Water    Ambion 
All other chemicals were purchased from Sigma-Aldrich. 
 
2.1.11 Instruments and Facilities 
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Dynapro Dynamic Light Scattering    Protein Solutions 
ND-1000 Spectrophotometer    NanoDrop (ZLH lab) 
Institute in-house DNA sequencing facility 
ÄKTA HPLC system     Amersham Biosciences 
Jasco J-810 Circular Dichroism Spectrapolarimeter Jasco (ZLH lab) 
In-house Rigaku FRE X-ray generator   Rigaku 
Synchrotron beam lines 
 XU-41  SPring-8, Japan 
 BX-7A DESY, EMBL outstation, Hamburg, Germany 
 ID-29  ESRF, Grenoble, France 
 ID-14  ESRF, Grenoble, France 
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2.2 Molecular cloning 
2.2.1. Yeast Genomic DNA extraction 
Wild-type Saccharomyces cerevisiae strain was inoculated into the YPUAD liquid 
media for overnight culture at 30 °C. 107 cells were harvested for each preparation and 
disrupted by micro-beads with the cell homogenizer. Genomic DNA was extracted 
with DNeasy Tissue Kit and precipitated in ethanol. Yeast DNA was air-dried and 
dissolved in buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA) in aliquots for storage at 
-20 °C.  
For genomic DNA extraction from fission yeast Schizosaccharomyces pombe, 
identical protocol was followed except that the YES liquid medium was used for cell 
culture. 
 
2.2.2 Yeast Total RNA extraction 
The procedure of cell growth and disruption was identical as above. RNeasy Mini 
Kit was used to extract total RNA. Purified RNAs were stored in RNase-free distilled 
water and treated with DNase I. The quantity and quality of RNA was examined by 
electrophoresis and UV260/280 absorption (NanaDrop).  
 
2.2.3 Reverse Transcription 
The reverse transcription reaction was carried out from yeast total RNA with 
ProSTAR Ultra HF RT-PCR system (Stratagen). The reaction was heated to 65 °C for 
5 minutes to inactivate the DNase I in the RNA sample prior to incubation at 42 °C 






Template   Plasmid, Genomic DNA, 1st strand cDNA 50 ng 
Primers  Forward and Reverse Primer (10 μM) 1 μl each 
Buffer   10X Pfu buffer    5 μl 
dNTPs   25 mM each of dATP, dCTP, dGTP, dTTP 1 μl 
Enzyme  Pfu turbo DNA polymerase (2.5 U/ μl) 0.5 μl 
Water   double-distilled water    to volume of 50 μl
   
DNA sequencing 
Plasmid   50-100 ng 
BigDye V3.1 mixture  8 μl 
Primer    125 ng  
The reaction volumn is 20 μl. 
 
Site-directed mutagenesis (QuikChange Site-Directed Mutagenesis Kit) 
Template   Plasmid     50 ng 
Primers  Forward and Reverse Primer    125 ng each 
Buffer   10X reaction buffer    5 μl 
dNTPs   40 mM each of dATP, dCTP, dGTP, dTTP 1 μl 
Enzyme  Pfu turbo DNA polymerase (2.5 U/ μl) 1 μl 




 PCR Programs 
General program 94°C   3 minutes, 1 cycle; 94°C 30 seconds, 55°C 45 
seconds, 72°C 2 minutes, 35 cycles; 72 °C 10 minutes, 
1 cycle 
Sequencing   96°C 10 seconds, 50°C 5 seconds, 60°C 4 minutes, 
 25 cycles 
Site-directed Mutagenesis 95°C 30 seconds, 1 cycle; 95°C 30 seconds, 55°C 1 
minute, 68°C 1 minute / kilo base of plasmid length, for 
18 cycles 
 
2.2.5 Construct subcloning 
The DNA fragments with unique restriction sites on both ends were subcloned 
into the same sites of pGEX-6p-1 vector. Restriction enzyme digestion was carried 
out in a 30 μl reaction containing 50-200 ng DNA, 0.5 μl of required restriction 
enzyme and 3 μl 10X buffer. The reaction was incubated at 37 °C for 3 hours, 
followed by DNA electrophoresis. Desired bands of vector or insert DNA fragments 
were excised and DNA was extracted with QIAGEN gel extraction kit. The mixture 
of insert and vector fragments of 1:1 ratio were ligated by T4 DNA ligase for 2 hours 
at room temperature. After that, 10 μl aliquot was transformed into E. coli DH5α 
competent cells, which were plated on LB agar plate overnight at 37 °C.  Individual 
colonies were inoculated into 3 ml LB medium and plasmids were extracted with 
QIAGEN miniprep kit.  Positive constructs were verified by restriction enzyme 
digestion and DNA sequencing. 
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 2.2.6 Transformation 
Plasmids or ligated products were transformed into E.coli competent cells by the 
heat shock method. For plasmid transformation, 0.5 μl plasmid was inoculated with 
50 μl of E. coli BL21 competent cells. For ligated construct or PCR product of site-
directed mutagenesis, 10 μl of DNA was mixed with 100 μl E. coli DH5α competent 
cells. After incubation for 20 minutes on ice, cells in the eppendorf tubes were bathed 
in water at 42 °C for 1 minute, followed by 10 minutes chilling on ice. Cells were 
recovered in 1 ml fresh LB medium at 37 °C for 1 hour before being streaked on the 
LB agar plate with appropriate antibiotics (100 mg/l ampicillin for pGEX-6p-1). 
 
2.2.7 Large-scale E. coli cell culture 
E. coli BL21 cells harboring the protein expression vector were inoculated into 50 
ml LB media with 100 μg/ml ampicillin for overnight culture at 37 °C. The small-
scale culture was diluted into 100-fold LB media supplemented with the same 
antibiotics on the next day and allowed to grow at 37 °C until O.D.595 reached 0.5. 
Cells were induced with 0.1 mM IPTG at 20°C overnight. Cells were harvested by 
centrifugation and the pellets were stored at -80°C. 
For Seleno-L-methionine (SeMet) substituted protein, E. coli cells were 
inoculated into 50 ml LB media with antibiotics for overnight culture at 37 °C. 
Culture was diluted 200-folds into 5 liter MOPS minimal medium with 10 mg Seleno-
L-methionine (Neidhardt et al., 1974). The subsequent steps of cell culture were 




2.3 Protein analysis 
2.3.1 Protein sequencing and Mass spectrometry 
Purified proteins on the SDS-PAGE were transferred to Bio-Rad PVDF 
membrane (25 V 1 hour), and stained with Coomassie blue to visualize the position of 
desired proteins. The protein bands were cut from the membrane and sent for protein 
sequencing by the Edman degradation method. 10 cycles were requested to identify 
the sequences in the N-terminus.   
For mass spectrometry to determine the molecular weight of the purified native or 
Se-Met proteins, samples were exchanged into distilled water and concentrated to 1 
mg/ml. The protein solution was submitted to the Proteomics Facility of IMCB for 
analysis. 
For MALDI-TOF to determine the protein identity, desired bands on the SDS-
PAGE gel after staining were excised and sent for protease digestion, mass 
spectrometry and data analysis by the Proteomics Facility of IMCB.  
 
2.3.2 Dynamic Light Scattering 
The purified protein was diluted in the sample storage buffer to 1 mg/ml and 
centrifuged at 13,000 rpm for 5 minutes to remove any precipitated materials. 20 μl of 
sample was injected into the cuvette for measurement at 25 °C. 10-15 measurements 
were carried out for each sample and results were analyzed with the program 
DYNAMICS V6 (Protein Solutions Inc). 
 
2.3.3 Protein concentration analysis 
Protein concentration was first determined by both Bradford assay (Pierrce) and 
UV280 absorption (Nanodrop) methods before further verification by SDS-
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polyacrylamide gel electrophoresis (SDS-PAGE). The protein molecular weight and 
extinction coefficient was computed with the ProtParam tool from the ExPASy server 
(Gasteiger et al., 2005). 
 
2.4 Functional Analysis 
2.4.1 GST pull-down assay 
The full length S. pombe Dcp1p (spDcp1p) was expressed as a glutathione S-
transferase (GST)-fusion protein in the E. coli BL21 strain. Clarified cell lysate was 
incubated with glutathione-Sepharose 4B beads at 4 °C for 1 h. After centrifugation, 
the beads were washed three times with the binding buffer (20 mM Tris-HCl (pH 7.6), 
150 mM NaCl and 2 mM DTT). The beads were then aliquoted and incubated with 
the purified wild-type and mutant S. pombe Dcp2 N-terminal domain (spDcp2n; 
residues 1-266) proteins for 1 hour on ice. The supernatants were removed and the 
beads were washed extensively with the binding buffer. The GST-tagged bait and the 
targeted proteins were eluted from beads with wash buffer supplemented with 20 mM 
GSH. The elution was resolved by 15% (v/v) SDS-PAGE and visualized by 
Coomassie blue staining. 
 
2.4.2 In vitro transcription 
The control λ DNA fragment of the T7 in vitro transcription kit was used for RNA 
transcription. The resulting 1.4 kb λ RNA products were precipitated with 2.5 M 
ammonium citrate and centrifuged at 4 °C for 15 minutes. The RNA pellet was 
washed with 70% chilled ethanol and air-dried. RNA was solublized in 50 μl 
nuclease-free water and its purity and concentration were determined by UV260/280 
absorption (NanoDrop). The aliquots were stored at -20 °C. 
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2.4.3 Preparation of Vaccinia Virus Capping Enzyme (modified from the protocol 
of Stuart Peltz’s lab at the State University of New Jersey) 
The E.coli BL21(DE3) strain transformed with capping enzyme pET construct 
pRP1069 was obtained from Roy Parker’s Lab. Cells were grown in 2 liter LB 
medium containing 0.1 mg/l ampicillin at 37 °C until O.D.595 reached 0.6. Culture was 
placed on ice for 30 minutes and continued to shake at 20°C for 48 hours without 
IPTG.  Cell pellet was resuspended in 50 ml lysis buffer (50 mM Tris HCl pH7.5, 
0.15 M NaCl, 10% sucrose) with 0.2 mg/ml lysozyme and 0.1% Triton X-100 for 30 
minutes on ice. Lysate was centrifuged at 18,000 rpm for 30 minutes at 4 °C to 
remove insoluble materials. 
The clarified lysate was mixed with Ni-NTA-agarose resin for 1 hour at 4 °C 
before forming a column. After washing the column with elution buffer, proteins were 
eluted stepwise with IMAC buffer (20 mM Tris HCl pH7.9, 0.5 M NaCl, 1mM PMSF, 
10% Glycerol) containing 5 mM, 50 mM, and 200 mM imidazole respectively. The 
50 mM fraction was exchanged into buffer A (25 mM Tris HCl pH 8.0, 0.5 mM 
EDTA, 1mM DTT, 0.05% Triton X-100, 5% glycerol) and proteins were fractionated 
by Heparin chromatography with buffer B as the elution buffer (25 mM Tris HCl pH 
8.0, 0.5 mM EDTA, 1mM DTT, 0.05% Triton X-100, 5% glycerol, 1M NaCl). The 
capping enzyme exists as heterodimer of 95 kDa and 31 kDa subunits and protein 
fractions were confirmed by SDS-PAGE. Finally, the capping enzyme was 
concentrated in the storage buffer (50 mM Tris HCl pH 8.0, 50 mM NaCl, 2.5 mM 
DTT 0.01% Triton X-100). Glycerol was added to a final concentration of 50% for 




2.4.4 RNA Capping 
For 45 μl reaction: 
4-6 μg in vitro transcribed RNA 
3 μl 15× capping buffer 
1 μl 20 mM S-adenosyl methionine (in 50 μM H2SO4) 
6 μl [α-32P] guanosine triphosphate (GTP) (3000 Ci/mM) 
1 μl 40 units/μl RNasin 
5 μl capping enzyme 
The reaction was incubated at 37 °C for 1-2 hours and capped RNA was purified 
with RNeasy Mini Kit to remove unincorporated [α-32P] GTP. Usually for the 45 μl 
reaction, RNA was eluted in 100 μl Nuclease-free water with > 3,600 counts per 
minute (cpm) per μl.  
 
2.4.5 Decapping Assay 
For 18 μl decapping reaction, 2 μl of 9X decapping buffer, 3000 cpm [α-32P] GTP 
cap-labeled mRNA and desired amount of protein were mixed and incubated at 37 °C 
for 30 minutes. The reactions were terminated by adding 2 μl of 0.5 M EDTA. 2mM 
MnCl2 was included in the decapping buffer in experiments specified. 
 
2.4.6 Thin Layer Chromatography 
The products of decapping reaction were analyzed by thin layer chromatography 
(TLC). A 20cm X 20cm cellulose PEI TLC plate (Sigma) was predeveloped in 
distilled H2O and a 3cm strip on the top of the plate was removed.  8 to 10 μl of each 
reaction was applied to the plate and developed in 0.75 M LiCl.  Cold 7-methylated 
guanosine diphosphate (m7GDP) was used as the marker, which is visualized under 
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the UV light at a wavelength of 254 nm. The radioactive products were visualized by 
autoradiography with Kodak films. Quantification was carried out by a phosphor-
imager for the original plates or by computer software for the developed films. 
 
2.4.7 Circular Dichroism  
The circular dichroism (CD) spectra were measured on a Jasco J-810 Circular 
Dichroism spectrapolarimeter at the wavelength ranging from 190 to 260 nm at a 
resolution of 0.1 nm. Both wild-type and mutant spDcp2n proteins were exchanged in 
the buffer containing 50 mM NaCl, pH 6.0 at the concentration of 10 μM and were 
transferred to a cell of 0.1cm path length. Three measurements were averaged for 
each sample and the molar ellipticity was calculated.  
 
2.4.8 in vivo and in vitro functional analysis by the collaborators (the following 
experiments were performed by Roy Parker’s lab) 
2.4.8.1 Biochemical analysis of mutant Dcp1 proteins.   
The mutations in S. cerevisiae Dcp1p (scDcp1p) were introduced into pRP1071, a 
plasmid designed to express both Flag-tagged full-length Dcp1p and a His -tagged N-
terminal 30-kDa fragment of S. 
6
cerevisiae Dcp2p (scDcp2p) in E. coli. The R29A 
D31A, W56A Y47A W204, and R70A alleles were introduced by PCR-amplifying 
the mutant allele from the corresponding yeast expression plasmid containing the 
mutant DCP1 gene using oligonucleotides oRP1162 and oRP1163, which introduced 
the Flag-tag at the N terminus of Dcp1p and a BamHI site at the 3' of the stop codon. 
The resulting PCR products were amplified with oRP1161 and oRP1163 to introduce 
a ribosome-binding site and an XbaI site 5' of the Flag-tag. The resulting PCR 
products were cut with XbaI and BamHI and used to replace the wild-type Dcp1 gene 
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in pRP1071. The additional mutant alleles were created using the QuikChange site-
directed mutagenesis kit (Stratagene). Y47A W56A was generated using the W56A 
plasmid, oRP1164 and oRP1165. L46AY47A was generated using the Y47A plasmid, 
oRP1166 and oRP1167. W56A K58A was generated using the W56A plasmid, 
oRP1168 and oRP1169. L46A Y47A K58A was generated using the L46A Y47A 
plasmid, oRP1174 and oRP1175. P32A I34A was generated using pRP1071, 
oRP1178 and oRP1179. L37A L38A L217A L221A was generated in two steps. First, 
pRP1071 was used as the template with oRP1204 and oRP1205 to introduce L37A 
L38A. Then, the resulting mutant plasmid was used as the template with oRP1206 
and oRP1207 to introduce L217A L221A. All mutant alleles were verified by 
sequencing. The wild-type and mutant Flag-tagged Dcp1 and His -tagged Dcp2 
proteins were co-expressed in DH5
6
α and purified as described. Western blot analysis 
against Dcp2p was carried out using standard protocols with monoclonal anti-His 
(Novagen). Cap-labeled 99 nucleotide MFA2 mRNA substrate was prepared as 
described. Decapping reactions were done in 20 μl volumes containing 50 mM Tris-
HCl, pH 7.5, 5 mM MgCl , 50 mM NH Cl, 1 mM DTT, 10 units RNasin (Promega), 
10 fmol substrate RNA and 0.12−1.2 
2 4
μg total protein. After incubation at 30 °C for 15 
min, a 2-μl aliquot was removed and reaction was stopped in this aliquot using 1 μl of 
0.5 M EDTA on ice. Products were separated on a PEI cellulose thin layer 





scDcp2n (residues 1-300), scDcp2ΔN (residues 102-970) and derivatives of 
scDcp2n carrying point mutations in the N terminus were inserted into pOAD and 
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scDcp1 was inserted into pOBD2 (Cagney et al., 2000).  Yeast strains PJ69-4A and 
PJ69-4α containing the pOAD-Dcp2 and the pOBD2-Dcp1 plasmids, respectively, 
were mated. Growth of the diploids was assayed on minimal selective media lacking 
leucine, tryptophan and histidine and containing 100 mM 3AT. 
For decapping assays with scDcp2n, uncapped RNA was transcribed and purified 
from MnlI-digested pRP802 as described (LaGrandeur and Parker, 1998).  The 99-
nucleotide RNA was capped using guanylyltransferase (Ambion) and [α- P] GTP 
according to the manufacturer's instructions.  Decapping was assayed in a 20-
32
μl 
reactions containing 20 fmol cap-labeled RNA, 50 mM HEPES (pH 7.0), 100 mM 
NaCl and 2 mM DTT. Intrinsic decapping activity was assayed in 2 mM MnCl  with 
20 ng scDcp2n and 80 ng BSA (Roche). Stimulation by scDcp1p was assayed in 5 
mM MgCl  with 100 ng scDcp2n and either 300 ng scDcp1p or 300 ng BSA. 
Reaction mixes were preheated at 30 °C for 2 min before the addition of proteins, 
incubated for 10 min at 30 °C then stopped by the addition of 10 
2
2
μl 0.5 M EDTA. 
Dcp1p or BSA was added just before Dcp2p. Aliquots of the reaction products from 
both types of decapping assays were spotted on polyethyleneimine-cellulose TLC 
plates (Sigma or Baker) and developed in 0.75 M LiCl. 
 
2.4.8.3 In vivo mRNA analysis  
S. cerevisiae strain yRP2061 (Matα ura3-52 lys2-201 leu2-3 trp1 
cup1::LEU2(PM) dcp2::TRP1) carrying the plasmids expressing wild-type or mutant 
versions of scDcp2p was grown to an OD  of 0.3–0.4 in the synthetic media lacking 
uracil and containing 2% (w/v) galactose. Total RNA was isolated as described 
(Caponigro et al., 1993) and was fractionated on 1.75% (w/v) formaldehyde agarose 
600
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gels. MFA2pG mRNA and its decay fragment were detected by northern analysis 
using oRP140 (Caponigro and Parker, 1995).
 
2.5 Protein purification, crystallization and structure determination 
2.5.1 Protein purification 
2.5.1.1 Cell disruption and GST-fusion protein affinity chromatography 
The frozen cell pellets were resuspended in 80-100 ml lysis buffer supplemented 
with 0.2 mg/ml lysozyme and incubated on ice for 30 minutes. Cells were 
homogenized by sonication (15 seconds on, 90 seconds off, for 8 cycles at 15 
amplitude microns). The lysate was separated by centrifugation at 18,000 rpm for 1 
hour. The clarified supernatant was loaded to the pre-equilibrated glutathione 
sepharose column and washed extensively with the lysis buffer. The GST-fusion 
protein was eluted in elution buffer and protein concentration is determined by 
Bradford assay. A 100-fold dilution of Preccission protease was added to the elution 
for GST-tag cleavage at 4°C overnight.  
 
2.5.1.2 Purification of scDcp1p 
Continued from the previous procedure (2.5.1.1), full-length scDcp1p (231 amino 
acids) with GST-tag cleaved was desalted into MonoS buffer A (20 mM Tris-HCl, pH 
7.8, 150 mM NaCl, 2mM DTT), then the sample was loaded to the regenerated GST 
column to remove the GST tag. Partially purified scDcp1p was further fractionated by 
ion exchange MonoS, after which the desired fractions were pooled and loaded onto 
the size exclusion gel filtration Superdex 75 26/60 column in running buffer (20 mM 
Tris-HCl, pH 7.6, 100 mM NaCl, 2mM MgCl2, 2mM DTT) at 1 ml/min. The 
recombinant scDcp1p exists as monomer in solution, as indicated by gel filtration 
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(Figure 8). The homogeneous proteins were concentrated to 10-14 mg/ml and stored 
as aliquot at -80°C.  
The purification procedure for SeMet scDcp1p was identical to that for the native 
one except that the concentration of DTT was increased to 10 mM in all buffers. 
 
Figure 8. Purification of recombinant S. cerevisiae Dcp1 protein. a) Dcp1p is 
eluted as a monomer of 27 kDa by the size exclusion chromatography column S75. 











2.5.1.2 Purification of S. pombe Dcp2 truncated protein 
As the N-terminal region of about 300 amino acids are conserved among Dcp2 
proteins and truncated protein containing this region is both necessary and sufficient 
for decapping in vivo, fragments corresponding of this region from S. pombe DCP2 
gene were inserted into the pGEX-6p-1 vector for recombinant protein expression. 
Four different GST- fusion S. pombe Dcp2 C-terminal truncations were expressed in 
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E.coli, consisting of 1-240, 1-266 (spDcp2n), 1-283, 1-310 residues respectively. The 
longer constructs containing 283 and 310 residues were prone to proteolytic 
degradation, while Dcp2(1-240) and Dcp2(1-266) were stable. Ion exchange MonoS 
and gel filtration S200 26/60 columns were used in subsequent purification. The 
recombinant S. pombe Dcp2 proteins were monomeric in the storage solution (20 mM 
HEPES 7.0, 200 mM NaCl, 2mM DTT), indicated by the size exclusion 
chromatography at a flow rate of 1 ml/min (Figure 9) and dynamic light scattering 
with an average radius of 3.4 nm. Only spDcp2n yielded diffraction-quality crystals. 
 
 
Figure 9. Purification of recombinant spDcp2n.  
a) spDcp2n is eluted as a monomer in the size exclusion chromatography column 
S200. b) SDS-PAGE of the purified spDcp2n proteins.  







2.5.1.3 Purification of mutant spDcp2n proteins 
For the expression and purification of the GST-fusion spDcp2n mutant proteins, E. 
coli cultures were scale-down to 500 ml and proteins were isolated by the batch 
method following the same procedure as that for wild-type spDcp2n. After two-step 
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GST affinity chromatography, the tag-free mutant proteins were of >95% purity. 
Circular dichroism spectrometry was carried out for both wild-type and mutants to 
ensure proper protein folding.  
 
2.5.1.4 Purification of the S. pombe Dcp1p-Dcp2NT complex (this experiment 
was performed by Nan Chen) 
The S. pombe Dcp1p-Dcp2NT complex containing the full-length Dcp1p and the 
interacting N-terminal domain of Dcp2p (residues 1-95, Dcp2NT) were purified as 
follows. GST-fusion S. pombe Dcp1p was purified following the protocol of scDcp1p 
with the gel filtration buffer containing 20 mM HEPES pH 7.3, 150 mM NaCl and 2 
mM DTT. Similarly, GST-fusion Dcp2NT was purified by a two-step GST-affinity 
chromatography and gel filtration using the same buffer as that for Dcp1p. 
Concentrated Dcp1p and Dcp2NT were mixed at 1:1 molar ratio for 2 hours at 4 °C 
before being loaded onto the S75 26/60 gel filtration column at 1 ml/min. The 
fractions containing the Dcp1p-Dcp2NT complex were pooled and concentrated to 25 
mg/ml for crystallization screening (Figure 10). 
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Figure 10. Purification of the S. pombe Dcp1p-Dcp2NT complex 
a) The gel filtration profile of the S. pombe Dcp1p-Dcp2NT complex on Superdex 








2.5.2 Protein Crystallization  
 The initial condition was screened with Hampton crystallization kits by the 
hanging-drop vapor diffusion method. The drop contained 1 μl protein of 10-25 
mg/ml and 1 μl crystallization solution, against 300 μl well solution.  The VDX boxes 
were kept in the 20 °C or 15 °C incubators and visually monitored 1 day, 3 days and 
one week thereafter. The crystals were havested and washed in the crystallization 
buffer and subjected to SDS-PAGE for verification. The crystallization condition was 
further optimized to obtain diffraction-quality crystals, and SeMet crystals were 
grown in the same conditions as the native ones with 10 mM DTT supplemented in all 
solutions. The crystals were transferred to the cryo-buffer with appropriate protectants 
and flash-frozen by liquid nitrogen. The buffer conditions for scDcp1p, spDcp2n, and 
S. pombe Dcp1p-Dcp2NT are summarized in Table 1. 
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2.5.3 Data collection and structure determination 
2.5.3.1  scDcp1p  
The dataset for SeMet scDcp1p crystal was collected on the beam line BL41-XU 
(SPring-8) at the Se K edge wavelength (λ= 0.9798 Å). The scDcp1p crystal belongs 
to space group P321 with the cell dimensions of a = b = 123.56 Å, c = 77.90 Å. The 
structure was solved at 2.3 Å resoluition by the single wavelength anomalous 
dispersion (SAD) method and four Selenium sites were found using SHELXD 
(Sheldrick, 1998). Refinement of the heavy-atom sites and phase estimation were 
performed with SHARP (de la Fortelle & Bricogne, 1997). The model was built with 
the program O (Jones et al., 1991) and refined with the program suite Crystallography 
& NMR System (CNS) (Brünger et al., 1991). The statistics for data collection and 
refinement  are summarized in Table 2. 
Table 1. Summary of protein crystallization buffers 
Crystal Crystallization conditions Cryo-protectant buffer 
scDcp1p 
(Se-Met) 
0.76 M (NH ) SO , 1.50 M NaCl, 5 
mM DTT, 0.1 M Tris-HCl, pH 8.5, 6 
mM EDTA, 2% isopropanol (v/v), 
20°C
4 2 4 0.76 M (NH ) SO , 1.5 M 
NaCl, 5 mM DTT, 0.1 M Tris-
HCl, pH 8.5, 6 mM EDTA, 2% 





5% PEG 200 (w/v), 1.4 M 
NaH PO , 0.6 M K HPO 20°C2 4 2 4  
2.5 M malonic acid (pH 6.5), 





0.1 M Ammonium Acetate and 
5% PEG3350, 20 °C 
2 mM TMLA overnight soaking 
0.1 M Ammonium Acetate and 
5% PEG3350, 25% Ethylene 
Glycol 2mM TMLA 
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2.5.3.2 spDcp2n   
The datasets of both native and SeMet spDcp2n crystals were collected at beam 
line ID29 (European Synchrotron Radiation Facility) at the wavelength of 0.9798 Å.  
The 2.7 Å SAD dataset were processed with CCP4 programs and 14 out of 16 
selenium sites in the asymmetric unit were located by SOLVE and SHARP 
(Collaborative Computational Project, Number 4., 1994; de la Fortelle and Bricogne, 
1997). After solvent flattening by SHARP, a partial model built with RESOLVE 
(Terwilliger, 1999) was used for manual model building with O. The model was 
refined with CNS and then REFMAC5 (CCP4) using the native data set at a higher 
resolution of 2.5 Å. A two-fold non-crystallographic symmetry restrain was applied in 
the process of model refinement. The final model has a good stereochemistry with a 
free R-factor of 28.7% (calculated form 5% of total reflections) and an R-factor of 
25.0% with 2 molecules in the asymmetric unit. The details of data collection and 
refinement statistics are shown in Table 3. 
 
2.5.3.3  The S. pombe Dcp1p-Dcp2NT complex  
The diffraction data for the crystals of the Dcp1p-Dcp2NT complex were 
collected using an in-house RIGAKU FR-E High Brilliance X-Ray Generator at the 
wavelength of 1.5418Å. The trimethyl lead acetate (TMLA)-soaked crystal belongs to 
the space group P212121 with cell parameters of a=42.7Å b=49.7Å, c=115.0Å, and 
there was one complex in the asymmetric unit. One Pb site was found by SnB (Weeks 
& Miller, 1999) and phase determination was achieved using SHARP by the single-
wavelength anomalous dispersion (SAD) method at 2.33Å. Full model was built with 
O. Refinement was done with the CNS and Refmac5 programs and the final model 
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has an overall R factor of 23.0% and free R of 26.7% (calculated form 5% of total 
reflections)(Table 4).  
 
Table 2. Data collection and refinement statistics of scDcp1p  
_____________________________________________________________________ 
Data collection 
Wavelength (Å)      0.9798 
Resolution range (Å)      50-2.2 (2.26-2.20) 
Reflections 
 Measured      286,716 
 Unique      34,251 
Completeness (%)      97.9 (97.9) 
I/σ        8.3 (1.9)a
R  (%)       6.6 (37.1) merge
 
Phasing 
Number of Se sites      4 
R 0.70 cullis        
Figure of Merit      0.86 
 
Refinement 
Resolution range (Å)      20.0-2.3 
Number of atoms 
 Protein       2571 
 Water       156 
R (%)       22.7 work
R (%)       26.8  free
R.m.s.d 
 Bond lengths (Å)     0.006 
 Bong angles (°)     1.3 
_____________________________________________________________________ 
a Values I the highest-resolution shell are shown in parenthesis. 
 60
 Table 3. Data collection and refinement statistics of spDcp2n  
________________________________________________________________________ 
 




Wave length (Å)   0.9792    0.9792       
Space group    P61    P61
dimensions 
 a, b, c (Å)   56.3, 56,3, 301.1  56.7, 56,7, 301.1 
 α, β, γ (°)   90, 90, 120   90, 90, 120 
Resolution range (Å)   20-2.5 (2.56-2.50)  20-2.7 (2.76-2.70) 
Rmerge(%)    9.1(52.3)   9.6(46.4) 
I/σ     21.9(4.0)   21.0(3.6) 
Completeness(%)   100(100)   100(100) 
Redundancy    10.0(7.5)   11.4(9.3) 
 
Refinement 
Resolution range (Å)    15-2.5 
Number of reflections    18,700 
Number of atoms 
Protein     3332 
water     111  
Rwork (%)     25.0      
Rfree (%)     28.7   (5%) 
R.m.s.d.  
Bond lengths (Å)   0.012 
Bond angles (°)   1.32 










Wavelength (Å)    1.5418     
Space group     P212121    
Cell dimensions 
 a, b, c (Å)    42.7, 49.7, 115.0   
 α, β, γ (°)    90, 90, 90    
Resolution range (Å)    20-2.33 (2.39-2.33)    
Rmerge(%)     8.1 (34.5)    
I/σ      7.6 (2.2)    
Completeness(%)    100 (99.5)    




Resolution range (Å)    20-2.33    
Number of reflections    10,420     
Number of atoms    1,820   
 Water     41    
 Ligand  `   1 Pb     
Rwork(%)     22.7     
Rfree(%)     25.9 (5%)     
R.m.s.deviations 
 Bond lengths (Å)   0.010     
 Bong angles (°)   1.26     
 Figures of Merit   0.82    
_____________________________________________________________________ 
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Chapter 3: Results 
 
3.1 Part I: Crystal Structure of scDcp1p 
3.1.1 Structural Overview 
Since the DCP1 gene was first identified in S. cerevisiae and the previous 
functional studies were carried out in yeast, the full-length scDcp1p protein was 
crystalllized for structural study.  The final model contains two copies of scDcp1p in 
the crystallographic asymmetric unit, designated as molecules A and B respectively 
(Figure 11a). No substantial differences are observed between the structures of two 
copies in the asymmetric unit (r.m.s. deviation of 0.60 Å for all the equivalent Cα 
atoms), so the following analyses refer to molecule B.  
The crystal structure of scDcp1p is composed of four α-helices and seven β-
strands, while the regions comprising of residues 1-16 and 81-134 are disordered. A 
notable feature of the tertiary structure is the formation of a central V-shaped β-
sandwich by two antiparallel β-sheets. An extended peptide and the short helix α1 lay 
in the N-terminus of the β-sandwich, and a long helix (α4) is flanking on the other 
side.  Two short helices α2 and α3, which are specific to scDcp1p only, are inserted 
between β4 and β5 (Figure 11b).   
 
3.1.2 scDcp1p belongs to the EVH1 family 
A search of the Protein Data Bank (PDB) using Dali, a network sever for protein 
three-dimensional structure comparison, indicated that scDcp1p belongs to the 
structural family of EVH1 domains including Mena (PDB: 1EVH; Z-score 12.9), and 
the Ran-binding protein (RanBP; PDB: 1RRP; Z-score 11.4) (Holm & Sander, 1993; 













Figure 11. Crystal structure of scDcp1p. a) Two Dcp1p molecules exist in the 
asymmetric unit: the molecule A (green) and the molecule B (magenta).  b) The 
crystal structure of Dcp1p showing the canonical EVH1 domain (magenta), the N-
terminal extension (blue) and the helices α2 and α3 (orange) specific to budding 
yeast.  c) Sequence alignment of the N-terminal conserved region of the Dcp1 
proteins from S.cerevisiae, S .pombe, C. elegans, D. melanogaster, X. laevis, M. 
musculus, H. sapiens respectively. The secondary structures of Dcp1p are 
















of the EVH1 domains. Superposition of the equivalent Cα atoms of scDcp1p and the 
other EVH1 domains gives rise to the r.m.s. deviation values of 1.70, 1.6, 1.7 and 1.8 
Å for Mena, Homer (PDB: 1DDV), N-WASP (PDB: 1MKE) and RanBP, respectively 
(Beneken et al., 2000; Volkman et al., 2002). Since the EVH1 domain is a subfamily 
of the PH domain, a module of about 120 amino acids that binds to 
phosphatidylinositol, the folding of scDcp1p is also similar to that of the PH domain 
(Figure 12f). The best matches for these structures are found in the core β-sandwich, 
with the larger deviations in the C-terminal α-helix (α4). The analysis is consistent 
with the prediction that human Dcp1a contains an EVH1 domain (Callebaut, 2002). 
Despite the similarities, some structural differences exist between the scDcp1p 
structure and the related structures. The N-terminal extended peptide of scDcp1p is 
reminiscent of the N-terminal extension of RanBP, but such an N-terminal extension 
does not exist in other EVH1 domains (Figure 12). This N-terminal extension seems 
to be functionally important, because mutations in this region can affect mRNA 
decapping in vivo (Tharun and Parker, 1999).  On the contrary, two short helices, α2 
and α3, and the large insert (residues 80-135) have no counterparts in other EVH1 
domains. Since the short helices and insert are only present in the budding yeast 
Dcp1p by sequence alignment, it is not likely to be central to Dcp1p function (Figure 
11b). 
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 Figure 12. Comparison of scDcp1p with the homologous EVH1/PH domains. 
a) scDcp1p. b) The Mena EVH1 domain in complex with an eight-residue peptide 
from ActA. c) The Homer EVH1 domain in complex with a five-residue peptide 
from mGluR. d) The NMR structure of N-WASP EVH1 domain with the WIP 
peptide. e) The RanBP EVH1 domain with a 25-residue peptide from Ran. f) The 





3.1.3 Analysis on scDcp1p surface to identify regions for potential Dcp2p 
binding (The biochemical experiments were performed by Parker’s group) 
Previous analyses of Dcp1p have indicated that Dcp1p interacts with several yeast 
proteins involved in decapping including Dcp2p, Dhh1p, Edc1p, Edc2p and Edc3p, 
although only in the case of Dcp2p there is clear evidence that the interaction is direct 
(Chapter 1.2.1). In order to identify the key regions on the Dcp1p surface for Dcp2p 
binding, the degree of amino acid conservation shared by the eukaryotic Dcp1 
proteins was mapped on the molecular surface of scDcp1p (Figure 13).  
This analysis revealed two prominent regions of structural conservation, 
designated as conserved patch 1 and patch 2. Patch 1 is situated in a concave V-
shaped groove formed by the β-strands 1, 2, 5, 6 and 7 (Figure 13a), corresponding 
structurally to the PRS-binding sites on other EVH1 domains (Figure 12b-d, & 
Chapter 1.3.1.1). This region of EVH1 domains forms a hydrophobic platform that 
interacts with proteins containing PRSs. Thus, the conserved patch 1 of scDcp1p may 
be a PRS-binding site. Consistent with this prediction, the N-terminal domain of 
hDcp1a/SMIF has been found to interact specifically with the proline-rich region 
(residues 275−308) of SMAD4 in the TGF-β signaling pathway (Bai et al., 2002). 
However, no similar PRS were found in the yeast Dcp1 interacting proteins such as 
Dcp2p. Nevertheless, the conserved patch 1 is still required for scDcp1p function in 
vivo, as an alanine-scanning mutagenesis experiment has shown that three mutations 
in this patch, W56A, Y47A and W204A, cause a partial loss-of-function phenotype 
(Tharun & Parker 1999)  
To probe the function of patch 1 biochemically, a series of mutations in this 
region were constructed. A system that allowed simultaneous assay on Dcp1p-Dcp2p 
copurification and stimulation on Dcp2 activity was used,  where Dcp1p was 
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coexpressed in E. coli with the N-terminal portion of Dcp2p (residues 1-300) (Steiger 
et al., 2003). The mutations tested include the single and multiple amino acid changes 
of the conserved residues to alanine. However, none of these mutations substantially 
reduced the amount of Dcp2p that copurified with Dcp1p relative to the wild-type 
Dcp1p (Figure. 14a). The finding that Dcp2p copurified with the mutants indicates 






Figure 13. Surface representation of scDcp1p. a) The sequence conservation 
shared by Dcp1 proteins are mapped on to the surface of Dcp1p with red color 
representing the highest degree of sequence identity and blue color the lowest 
(performed with the programs ClustalW, ConSurf and GRASP). The cluster of 
invariant residues in patch 1 corresponds to the putative PRS-binding site of the 
EVH1 domain. b) Surface view of the conserved patch 2, which is a 180 ° rotation 
along y-axis with respect to panal a. 
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The effects of these mutations on Dcp2p decapping were assayed by measuring 
the decapping activity of Dcp2p in the same copurification system. The reactions 
were carried out in vitro in the absence of manganese, a condition under which yeast 
Dcp2p is dependent on Dcp1p for measurable activity (Decker and Parker, 
unpublished data). In general, most of the mutations in patch 1, including a triple 
mutant (L46A Y47A K58A), did not substantially affect the decapping activity of the 
Dcp1p-Dcp2p complex (Figure 14b).  
Changing Trp56 to alanine, alone or in combination with the Y47A or K58A 
mutations, did however reduce the decapping activity. The reduction in decapping in 
these mutants is most likely due to the W56A mutation, because the Y47A or K58A 
mutation alone or in combination with mutations other than W56A did not reduce 
decapping. Because Trp56 is absolutely conserved in all EVH1 folds and mutation of 
the corresponding residue (Trp23) in the Mena EVH1 protein alters its structure (Ball 
et al., 2002), Trp56 may have some structural role in Dcp1p. Given that most of the 
mutations in patch 1 did not affect decapping, one possible function of patch 1 is to 
enhance some biochemical properties of the enzyme not assessed in the current assays. 
Alternatively, the lack of a strong biochemical phenotype for changes in this 
conserved surface suggests that patch 1 may have a role in contacting regulatory 
proteins not present in this purified system. 
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 In scDcp1p, there is a second highly conserved patch, which consists of two 
charged residues, Arg70 and Asp31, and three hydrophobic residues, Tyr68, Pro32 
and Ile34 (Figure 13b). Patch 2 is located on a concave surface directly opposite the 
putative PRS-binding site formed by the N-terminal 310-helix and β-strands β1−β4 
(Figures 11b and 13b). Structurally, this region is analogous to the hotspot of disease 
a
b
Figure 14. Biochemical assay of mutations in conserved patch 1 of scDcp1p.  
a) The wild-type and mutant alleles of Flag-tagged Dcp1p were coexpressed with 
the His-tagged Dcp2(1-300) fragments. The amount of proteins was detected by 
western blot (Dcp2p) or silver staining (Dcp1p) b) Decapping assay of Dcp2p 
copurified with the wild-type or mutant Dcp1p. The efficiency of reaction is 
indicated by the amount of m7GDP.released. The percentage of activity of mutant 
compared with the wild-type protein is plotted on the right panel, averaged from 
four independent experiments. 
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mutations found in the N-WASP EVH1 domain (Volkman et al., 2002) and to the 
region where residues 178-181 of Ran interact with the RanBP EVH1 domain (Vetter 
et al., 1999) (Figure 12d, e). In support of patch 2 being functionally important for 
Dcp1p, mutation of Arg70 or Asp31 to alanine inhibits decapping in vivo and leads to 
an inhibition of the decapping activity of the protein purified from yeast cells (Tharun 
and Parker 1999). Similarly, mutation of the homologous residues Asp20 and Arg59 
in human hDcp1a decreased the decapping activity of the immunopurified protein 
complex from cells (Lykke-Andersen, 2002).  
A series of mutations in patch 2 were constructed and these Dcp1p mutants were 
purified in the same system coexpressing Dcp2p to study the function of patch 2 in 
vitro (Steiger et al., 2003). Three alleles with mutations in both conserved charged or 
hydrophobic residues were tested, including the double mutants R29A/D31A, 
P32A/I34A, and the single mutant R70A.  All the mutant Dcp1 proteins copurified
with approximately equal amounts of Dcp2p relative to the wild-type Dcp1p (Figure 
15a). This suggests that patch 2 is not required for Dcp1p and Dcp2p interaction. 
However, the mutations of the charged residues (Arg29, Asp31 and Arg70) in
patch 2 caused severe defects in the decapping activity of the copurified Dcp1p-
Dcp2p (Figure 15b, lane3-4). Similarly, changing two hydrophobic residues in this 
patch led to a partial defect in the decapping activity (Figure 15b, lane5). These 




Dcp1p-Dcp2p. In addition, because Dcp2p was still copurified with these point 
mutants, these results indicate that at least one function of this region is independent 
of its role as a binding site for Dcp2p. In this regard, possible functions for patch 2 
would include directly binding substrate, or promoting an activating conformational 




Figure 15. Biochemical assay of the mutations in the conserved patch 2 of 
scDcp1p. a) Dcp2p coexpressed with the wild-type or mutant Dcp1p. b) 




In addition to the two conserved patches, a hydrophobic patch is critical for the 
function of Dcp1p. Mapping of the side chains of hydrophobic residues on the 
molecular surface of Dcp1p reveals that a large hydrophobic patch is located close to 
patches 1 and 2 (Figure 16a). To examine the role of this hydrophobic patch in 
Dcp2p binding and decapping, a quadruple mutant in which Leu37, Leu38, Leu217 
and Leu221 were all mutated to alanine was constructed. Approximately equal 
amounts of Dcp2p copurified with the mutant protein as with the wild-type Dcp1 
protein (Figure 16b). This result suggests that this hydrophobic surface is not 
absolutely required for Dcp1p to interact with Dcp2p. However, it is still possible that 
the hydrophobic surface affects the strength of the interaction. Although the L37A 
L38A L217A L221A mutations did not substantially affect Dcp2p binding, it did 
cause a strong defect in decapping (Figure 16c), indicating that this surface is 
required for Dcp1p to enhance decapping. Given the proximity of the hydrophobic 
patch to patch 2 and the fact that both patches are required for Dcp1p function, these 
two features of the protein may function together to promote decapping by Dcp2p. 
 
In conclusion, conserved patch 2 and a hydrophobic patch are all involved in the 
decapping activity of the Dcp1-Dcp2 complex, although the mutations in these 
regions do not exclusively disrupt protein-protein interaction.  As the current 
structural model is not complete (lacking first 22 residues in mol A and first 16 
residues in mol B, in addition to central insertion of residues 81-134), it is possible 
that certain region with the functional significance has not been explored in this study 
and more experiments and structures are required to locate the protein-protein 









Figure 16. Biochemical assay of the mutations in the hydrophobic surface 
 The hydrophobic surface is shown in green with the conserved 
residues labeled in olive and the non-conserved ones in black (figure is generated 
with GRASP). The positions of conserved patch 1 and 2 are indicated with arrows. 
b) The protein level of the wild-type or mutant Dcp1p coexpressed with Dcp2p. c) 
Decapping activity of the wild-type or mutant Dcp2p in complex with Dcp1p. 
patch of Dcp1p. a)
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3.2 Part II: Crystal structure of spDcp2n 
3.2.1 Structural overview 
In the Dcp2 proteins from various organisms, the N-terminal regions of about 250 
amino acids are highly conserved and are essential for cellular function (Figure 6). 
The crystal structure of the first 266 amino acids of S. pombe Dcp2 protein, or 
spDcp2n, was solved at a resolution of 2.5 Å. The structure contains two molecules 
(A and B) in the asymmetric unit, related by non-crystallographic symmetry (NCS) 
(Figure 17a). No substantial differences are observed between molecules A and B 
(r.m.s. deviation of 1.2 Å for all the equivalent Cα atoms), and all subsequent analyses 
are based on molecule A.  
The crystal structure of spDcp2n contains two distinct domains: an all α-helical N-
terminal domain followed by a Nudix domain (Figure 17b). The N-terminal domain 
(residues 1-95) is formed by six α-helices and is connected by a short hinge linker to 
the Nudix domain (residues 98-245). The Nudix domain consists of a six-stranded β-
sheet flanked by two α-helices on both sides, thereby forming an α/β/α sandwich 
structure, and the signature Nudix motif per se forms the central loop-helix-loop 
module. The model is largely complete with a few disordered regions, namely 







Figure 17. The Crystal structure of spDcp2n. a) The ribbo
c 
n digram of two 
copies of spDcp2n molecules in the asymmetric unit, and molecule A is more 
complete (PDB code: 2A6T). b) The ribbon diagram of spDcp2n molecule. The N-
terminal domain is shown in orange and the Nudix domain is shown in green, with 
the Nudix motif highlighted in red. c) The schematic diagram of the domain 
organization of full-length spDcp2p. The N-terminal region with crystal structure 




3.2.2 Nudix domain as the catalytic center 
Consistent with the observation of the conserved Nudix motif in the Dcp2 protein, 
a search of the Protein Data Bank using the Dali server indicated that spDcp2n is 
highly similar to the Caenorhabditis elegans Ap4A pyrophosphatase (or Ap4AP; 
1KT9; Z = 13.7) (Bailey et al., 2002) and the Escherichia coli ADP-ribose 
pyrophosphatase (or ADPRP; 1G0S; Z = 13.1) (Gabelli et al., 2001), despite the low 
sequence identities among these proteins. The structural similarity is seen only in the 
Nudix domain of spDcp2n (Figure 18). Moreover, when a Dali search was carried out 
using the N-terminal helical domain alone as bait, no structural homolog (Z > 4.5) was 
found, suggesting that the N-terminus domain probably represents a novel fold. 
Figure 18. Comparison of spDcp2n with other Nudix enzymes a) The ribbon
diagram of spDcp2n, with the nudix motif highlighted in red. b) The structure of the 
monomeric Ap4AP in complex with a phosphate and an AMP (PDB: 1KTG) in the
same orientation as spDcp2n. c) The structure of the dimeric ADPRP in complex
with an ADP-ribose substrate (PDB: 1G9Q). One of its subunit is shown in green in 
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Superposition of the Nudix domain of spDcp2n with those of Ap4AP and ADPRP 
giv
ivities 
es rise to the r.m.s. deviation values of 1.6 and 1.7 Å, respectively. The core 
architecture of the Nudix folds is very similar among these structures, with the best 
match being the central β-sheets (Figure 18b-c). The structure also corrects one 
mistake in previous reports, in which the conserved Box B (residues 217–236) was 
predicted to be outside of the Nudix domain (van Dijk et al., 2002; Wang et al., 2002b; 
Figure 6). Actually, the Box B region is an essential component of the α/β/α 
sandwich of the Nudix domain, forming a long α-helix (α8) that is equivalent to the 
helix α3 in both Ap4AP and ADPRP (Figure 18). Consistent with this observation, 
the minimal fragment of human Dcp2 with the RNA-binding and decapping act
requires Box B (Piccirillo et al., 2003), presumably because the absence of Box B 
would destabilize the whole Nudix fold and/or Box B actually contains the mRNA-
binding site. 
The consensus sequence for the Nudix motif of the Nudix hydrolase family is 
GX5EX7REUXEEXGU, in which X is any residue and U is Ile, Leu or Val (Bessman 
et al., 1996; Mildvan et al., 2005). Although the precise mechanism of different Nudix 
hydrolases varies, in general, two or three of the conserved glutamate residues at the 
16th, 19th and 20th positions within the Nudix motif are involved in coordinating a 
divalent cation crucial for catalysis. In addition, one of the glutamates in the motif 
may act as a general base in the nucleophilic attack. 
In Ap4AP, a monomeric protein that hydrolyzes a diphosphate linkage in the 
AppppA substrate, the conserved residues Glu52, Glu55, Glu56 and Glu103 are 
critical for activity.  Glu52, Glu55 and Glu56 correspond to the 16th, 19th and 20th 
glutamate in the consensus sequences of the Nudix motif, while Glu103 is an essential 
residue outside of the nudix motif. These glutamic acid residues have been implicated 
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in m
retable electron density in the structure of the apo enzyme, and it 
und
the glutamate residues in the 16th 
pos
agnesium binding and the nucleophilic attack of the pyrophosphate bond. The 
mutation of Glu52, Glu56 or Glu103 to Gln results in a 103-, 105- or 30-fold reduction 
in the kcat value respectively, suggesting that Glu56 is the major residue for catalysis 
while Glu52 and Glu103 contribute to activity to a less extent (Abdelghany et al., 
2003).  
The structural comparison of the key residues of spDcp2n and Ap4AP showed 
that Glu143 and Glu147 of spDcp2n are able to be superimposed with the Ap4AP 
active site residues Glu52 and Glu56, yet the side chain of Glu192 is pointing away 
from the catalytic center of spDcp2n, in contrast to its counterpart Glu103 in the 
structure of Ap4AP in the binary complex form (Figure 19a). Glu192 is located near 
the disordered region (residues 185-191) and is less well defined in the electron 
density map. Notably, the loop L6 (residues 93–106) containing Glu103 in Ap4AP 
has no interp
ergoes a conformational change and becomes ordered upon ligand binding (Bailey 
et al., 2002). It is tempting to speculate that the region of residues 185-191 in Dcp2p 
may become ordered upon substrate binding and the side chain of Glu192 may be 
oriented to the optimal position for metal binding, or catalysis, or both. The similarity 
between the active site structures of spDcp2n and Ap4AP suggests that residues 
Glu143, Glu147 and Glu192 might have important roles in catalysis as well. 
In the budding yeast and human Dcp2 proteins, 
ition of Nudix motif has been shown to be absolutely required for decapping 
activity (van Dijk et al., 2002; Wang et al., 2002b; Dunckley & Parker 1999). In order 
to determine whether equivalent glutamate and probably additional residues are 
required for decapping in spDcp2n, Glu143, Glu147 and Glu192 were substituted by 
alanine or glutamine. In vitro decapping assay shows that all three mutations 
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abolished the decapping activity of spDcp2n (Figure 19b), suggesting that similar to 
Ap4AP, Glu143, Glu147 and Glu192 are important for the activity, probably by 
serving as a general base or by coordinating a divalent cation.  A crystal structure of 
Dcp2 protein containing the substrate and cation in the active site will provide the 




Figure 19. The Nudix motif of spDcp2n is the catalytic center. a) Superposition 
of the Nudix motifs and its adjacent regions in spDcp2n (purple) and Ap4AP 
(green). The key glutamate residues involved in catalysis are shown as sticks. b) In 
vitro decapping assays of the wild-type and mutant spDcp2n.  
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3.2.3 The function of the N-terminal domain  
The function of key residues in the Nudix domain in mRNA decapping is 
consistent in the Dcp2 protein, which is a member of the Nudix hydrolase family.  
However, the function of the N-terminal domain remains obscure and there is no 
structural homolog.  It is possible that the N-terminal domain contributes to decapping 
 
 
activity, although the active site is in the Nudix domain.  In certain multi-domain 
Nudix hydrolases, the N-terminal extension preceding the Nudix fold plays a role in 
regulation (Mildvan et al., 2004).  Moreover, the Dcp2 protein can interact with other 
regulating factors, most notable of which is the Dcp1 protein. Previous studies have 
demonstrated that Dcp2 physically interacts with Dcp1 in H. sapiens, S. cerevisiae 
and S. pombe and in S. cerevisiae, the formation of the Dcp1-Dcp2 complex affects 
decapping both in vivo and in vitro (van Dijk et al., 2002; Steiger et al., 2003; 
Dunckley & Parker 1999, Lykke-Andersen 2002). Therefore, the decapping activity
and Dcp1p binding affinity of individual domains were examined to provide insight 
into the general function of the Dcp2p N-terminal domain.  
Firstly, the decapping activity of the purified spDcp2n lacking either the Nudix 
domain or the N-terminal domain was tested to determine whether N-terminal domain 
was required for activity. The N-terminal domain alone (residues 1–95; Dcp2NT) has 
no decapping activity at all, whereas the Nudix domain alone (residues 96–266; 
Dcp2CT) can decap cap-labeled RNAs, albeit with reduced decapping activity 
compared to spDcp2n even in the presence of Mn2+, the divalent cation that can 
strongly augment the activity of the Dcp2 protein (Figure 20a). This observation
suggests that the N-terminal domain is not absolutely required for the intrinsic 
decapping activity of Dcp2p protein but can increase the Dcp2p function in vitro. The 
impaired activity of the Nudix domain cannot be restored by the reconstitution of the 
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separately purified domains in vitro, as the equal molar mixture of Dcp2NT with 
Dcp
 
2CT has similar decapping activity to that of Dcp2CT alone (Figure 20a, lane 
5,9). This result implies that the maximal decapping activity of Dcp2p requires the 





















Figure 20. The functional analysis of two individual domains of spDcp2n. a) In 
vitro decapping assay of the Dcp2 fragments in the presence of Mg  or Mn . b) 
The GST-pulldown assay. The GST-fusion Dcp2 fragments were tested for their 





































Figure 21. Sequence alignment and the surface view of spDcp2n.  a) Sequence 
alignment of the N-terminal regions of Dcp2p proteins from various species with the 
program ClustalW. b) The surface presentation of the sequence conservation on 
Dcp2n with conserved residues shown in red and variable ones in blue. The figure 
was generated with the programs ConSurf and GRASP. The highly conserved 
residues are labeled. The right panel is a 180 ° rotation along y-axis of the left panel. 
Next, the possible roles of the N-terminal domain and the Nudix domain of Dcp2p 
in interacting with Dcp1p were examined by the GST-pulldown assay, in which GST-
fusion spDcp1p was immobilized on beads to retain the two Dcp2p truncation variants 
(Figure 20b). The results showed that Dcp2NT alone is necessary and sufficient for 
Dcp1p binding, whereas Dcp2CT is not required for interaction with Dcp1p. The 
association of Dcp2NT with Dcp1p is strong, as the complex is resistant to 500 mM 
NaCl. In addition, the gel filtration and dynamic light-scattering experiments using 
purified spDcp2n and spDcp1p confirmed this interaction and showed that two 
proteins form a complex of 1:1 stoichiometry. 
 
3.2.4 The Dcp1p binding site 
In order to identify the critical residues that are involved in Dcp1p binding and 
regulate decapping activity, the degree of sequence conservation shared by the Dcp2 
proteins across species was mapped onto the molecular surface of the spDcp2n. This 
analysis revealed two prominent conserved regions (Figure 21). One of the regions is 
situated in the Nudix domain and corresponds to the Nudix motif, as expected. The 
other region, formed mainly by the residues from Box A, is located on one side of the 
N-terminal helical domain.   
GST-fusion Dcp1p pull-down assay was performed to check whether the point 
mutation in spDcp2n N-terminal domain disrupts the interaction between Dcp1p and 
Dcp2p. Interestingly, three mutations show defects in Dcp1p binding clearly, while 
the rest behave similar to the wild-type spDcp2n (Figure 22a). Mutation of Phe19 to 
alanine abolished Dcp1p binding in vitro, and the substitution of Arg18 and Phe44 by 




tered on one side of the N-terminal domain, correlating with a patch of 
hydrophobic surface (Figure 22 b-c). 
Therefore, the results indicate that one function of the conserved patch on the N-
terminal domain of Dcp2p is to bind Dcp1p, with residues Arg18, Phe19 and Phe44 
being important for this interaction, probably through hydrophobic interaction.  
 
Wt R18AF19A R33AF36A E39AW43AF44AD47AF48AY92AK93A 
a 
b c 
Figure 22. The spDcp1p binding region in the Dcp2n N-terminal domain. a) 
G
programs ClustalW, ConSurf and GRASP. 
ST-fussion Dcp1p was used to pulldown tag-free wild-type spDcp2n or mutants 
with single residue substituted by alanine. Three residues involved in Dcp1p 
binding are highlighted. b) The surface representation of the conserved regions in 
the N-terminal domain of Dcp2n. The positions of Dcp1p-interacting residues are 
labeled. c) The Surface representation of the hydrophobic area of spDcp2n. The 
hydrophobic residues are colored in green. The figures were generated with the 
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3.2.5 Dcp1p stimulates Dcp2p decapping activity 
In budding yeast, the Dcp1 protein can significantly enhance the Dcp2 protein 
dec
e2-5). 
In contrast to the wild-type protein, the spDcp2n mutants R18A, F19A and F44A, 
which have defects in Dcp1p binding (Figure 22a), were not stimulated by spDcp1p 
(Figure 23a, lane 6-17), indicating that the enhancement of Dcp2p activity by Dcp1p 
requires interaction of the two proteins. Although R18A and F19A mutants exhibit 
lower activity than the wild-type protein, the inability of the mutant proteins to be 
stimulated by spDcp1p was not due to the mildly reduced decapping activities, as 
mutants R33A, E39A and W43A also have reduced activity but are capable of binding 
spDcp1p and are still stimulated by spDcp1p (see below). 
A previous study has shown that the N-terminal domain is not required for 
catalytic activity but can affect the efficiency of Dcp2p function (Figure 20a).  
Further evidence came from the in vitro analysis of the point mutations of other 
conserved residues within the N-terminal domains of spDcp2n. These mutations 
targeted mainly residues within Box A as well as two conserved residues (Tyr92 and 
Lys93) at the C terminus of the N-terminal domain and are all located on the 
conserved face of the N-terminal domain (Figure 21). Although no mutation within 
the N-terminal domain abolished recombinant spDcp2p function in vitro, several 
residues were required for the optimal decapping activity (Figure 23b). Specifically, 
mutations of Arg33, Glu39, Trp43, Asp47 and Lys93 to alanine partially decreased 
the decapping activity in the presence of Mg2+, whereas mutation of Phe36 to alanine 
had no substantial effect on the decapping activity. The defects of the spDcp2n 
apping activity, a phenomenon not observed in the higher eukaryotic system. It 
was demonstrated in this study (Chapter 1.3.1) that, similar to budding yeast, 
recombinant spDcp1p could stimulate Dcp2p activity in vitro (Figure 23a, lan
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mutants in decapping are not due to the misfolding of these mutants, as the circular 
dichroism spectroscopy gave very similar spectra for the wild-type and mutant 
spDcp2n proteins (data not shown).  Consistent with the notion that these residues are 
not involved in spDcp1p binding, the addition of spDcp1p in the reaction stimulates 
the decapping activity of the mutant enzymes to several folds, with the only exception 
of Lys93. Residue Lys93 forms a salt bridge with Asp47, thus the low activity of 
K93A mutant might be due to its inability to retain proper conformation of the N-
terminal domain of spDcp2n.  
Together, the results of the S. pombe Dcp2 protein demonstrate that spDcp1p 
stimulates the decapping activity of spDcp2p through its physical interaction with the 
N-terminal domain of spDcp2p.  
 
3.2.6 in vivo and in vitro study of S. cerevisiae Dcp2 protein (The following 
experiments were carried out by Roy Parker’s lab in the University of Arizona) 
The in vitro functional analysis in the previous text is based on the structure of S. 
pombe Dcp2n. However, it is not clear whether the key residues have similar roles in 
vivo as in vitro.  Since mRNA decay is extensively studied in S. cerevisiae and both 
yeast Dcp2 proteins share a high level of homology, in vivo experiments were carried 
out in S. cerevisiae to further confirm the in vitro results. The corresponding 
constructs followed the same nomenclature as S. pombe proteins, with the sc- prefix 
standing for S. cerevisiae. 
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Figure 23. spDcp1p stimulates the decapping activity of spDcp2n. a) The 
decapping activity of the wild-type spDcp2n is increased via its interaction with 
spDcp1p. spDcp2n with the single mutation in the residues that are required for 
spDcp1p binding can not be stimulated. b) Histogram showing the ratio of 
increased activity in the presence of 1-fold, 3-fold and 10-fold excess of spDcp1p. 
c) The decapping activity of the wild-type and other mutants which are not 
required for spDcp1p binding in the presence of 3-fold excess of spDcp1p.  d) 
Histogram showing the decapping activity of individual reaction of panel c. 
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First of all, to determine whether the N-terminal domain of scDcp2p had any 
important function in vivo as spDcp2p (Chapter 3.2.3), the N-terminal deleted protein 
was introduced into a dcp2Δ strain and assayed the effect of the deletion on the 
dec
s the level of mRNA decay intermediate can be 
detected by specific probe against the 3’UTR of MFA2pG mRNA. In the wild-type 
igure 
24b
s in the N-terminal domain are important for decapping in 
vivo, the conserved residues corresponding to those revealed from the surface 
mapping of the spDcp2n structure were identified and mutated to alanine (Figure 
24a). Most of the point mutations reduce decapping, but to varying degrees (Figure 
24c). The W50A and D54A mutations had a very strong effect on decapping, causing 
an approximately eight-fold increase in the ratio of full-length mRNA to the decay 
fragment. The R25A, Y99A and K100A mutations also caused a strong defect in 
decapping, increasing the ratio between three- and five-fold, whereas the F26A, R40A, 
F43A and E46A mutations had only a modest effect on decapping. Western analysis 
demonstrated that all these mutant Dcp2p proteins were expressed at levels 
apping of the MFA2pG mRNA (Caponigro and Parker, 1995). This modified 
MFA mRNA has a poly(G) tract in the 3’UTR, which blocks further process by the 
5’→3’ exonuclease Xrn1p. Thu
cells, the MFA2pG mRNA decay intermediate resulting from decapping and decay is 
abundant, while in dcp2Δ cells, there was no detectable intermediate present (F
). In the cells that express scDcp2p lacking residues 1–101 (scDcp2ΔN, residues 
102-970), there was also no MFA2pG intermediates released even though scDcp2ΔN 
still contains the catalytic Nudix domain. The 1–101 deletion did not reduce the 
amount of protein expressed; therefore the lack of decapping was not simply due to 
destabilizing the scDcp2ΔN in vivo (Figure 24d). This result indicates that the N 
terminus of scDcp2p protein is absolutely required for decapping in vivo.  
To define what residue
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comparable to that of the wild-type Dcp2p (Figure 24d). Thus, the scDcp2p function 
in vivo also requires the specific residues on the conserved surface of the N terminus. 
In vitro pull-down experiment with spDcp2n (residues 1-266) had identified 
hydrophobic patch consisting of Arg18, Phe19 and Phe44 as the spDcp1p binding site 
(Chapter 3.2.4).  Similar pull-down experiments were not performed with S. 
cerevisiae Dcp1 and Dcp2 proteins because scDcp2p is highly insoluble and reliably 
physical interaction between recombinant Dcp1p and Dcp2p was not detected unless 
they could be coexpressed (Steiger et al., 2003). To verify these Dcp1p-Dcp2p 
interactions, a yeast two-hybrid assay was used to examine what residues of scDcp2p 
affected scDcp1p interaction. The scDcp2n truncation containing the conserved 
region only (residues 1-300) was fused to the Gal4 activation domain and scDcp1p to 
the Gal4 DNA-binding domain, and their interaction was assayed by cell growth on 3-
aminotriazole (3AT). scDcp1p interacts with scDcp2n, rather than scDcp2ΔN lacking 
the N-terminal domain (Figure 25a). When scDcp2p containing a series of point 
mutations in the N terminus were tested, mutations in Arg25, Phe26 and Phe51 
disrupted the interaction between Dcp2p and Dcp1p specifically. The other point 
mutations tested had no detectable effect on the two-hybrid interaction between 
Dcp2p and Dcp1p. Notably, Arg25, Phe26 and Phe51 in scDcp2p correspond to 
Arg18, Phe19 and Phe44 in spDcp2p, which affected the Dcp1p-Dcp2p interaction in 
vitro (Figure 22a and Figure 25a). Therefore, multiple assays identify the same 
conserved residues as being important for Dcp1p-Dcp2p interaction in both budding 
and fission yeast. 
As for stimulation effect of scDcp1p, similar, but not identical, results were 
obtained with scDcp2n, compared with the experiments with pombe proteins. 
scDcp2n has very weak activity in the presence of Mg2+, which is increased 
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substantially by the addition of scDcp1p (Figure 25b). For scDcp2n, a wider 
spectrum of mutations in the N-terminal domain affected the ability of Dcp1p to 
stimulate the enzyme. Specifically, scDcp1p did not stimulate the R25A, F26A, E46A, 
W50A, F51S, D54A or K100A mutants of scDcp2n.  Mutants R25A, F26A and F51S, 
corresponding to mutants R18A, F19A and F44A in spDcp2n, respectively, have 
strong defects in scDcp1p binding. The results confirmed that in budding yeast, 
stimulation by scDcp1p is likewise mediated by the Dcp1-Dcp2 interaction via these 
three conserved residues.  The wider spectrum of alleles affecting Dcp1p activity in 
the S. cerevisiae enzymes compared to those of S. pombe may result from the weaker 
activity of scDcp2n by itself when compared to that of spDcp2n; spDcp2n is 
markedly more active than scDcp2n in the presence of Mg2+. In contrast to the other 
mutants, the scDcp2n proteins with the R40A and F43A mutations were stimulated by 
the addition of scDcp1p, which is consistent with these positions not affecting binding 
between Dcp1p and Dcp2p in both S. cerevisiae and S. pombe (Figure 25b and 
Figure 23c).  
In conclusion, the in vitro results using S. pombe proteins were duplicated by the 
in vivo experiments in S.cerevisiae, confirming that the functions derived from the S. 














Figure 24. In vivo decapping assay of S.cerevisiae Dcp2p. a) The numbering of 
conserved residues of Dcp2p in S.cerevisiae and that of counterparts in S.pombe. 
b) Northern analysis of the steady-state level of MFA2pG mRNA containing 
poly(G) tract in the 3’UTR. The N-terminal 300 residues are absolutely required 
for decapping. c) Northern analysis of the steady-state level of MFA2pG mRNA in 
scDcp2p mutants d) Northern analysis of the steady-state level of MFA2pG 
mRNA in cells expressing the wild-type and mutant scDcp2p. Western analysis of 
endogenous wild-type and mutant GFP-Dcp2 proteins detected by anti-GFP 
antibody. The levels of expressed proteins are similar. Lower bands indicated with 








Figure 25. The analysis of scDcp1p-scDcp2n interaction and decapping 
stimulation. a) Two hybrid analysis of the interaction between scDcp1 fusion to 
the Gal4 DNA-binding domain and scDcp2n (residues 1-300) fused to the Gal4 
ac
ld-type and mutants in 
the absence and presence of scDcp1p.  
tivation domain. The growth defect on the minimal selective plate without 
histidine but 100 mM 3AT indicates the disruption of Dcp1p and Dcp2p 
interaction. b) In vitro decapping assay of the scDcp2n wi
Part III:  Structural basis for S. pombe Dcp1p and Dcp2p interaction 
3.3.1 Structural Overview of the S. pombe Dcp1p-Dcp2NT complex 
The structure of S. pombe Dcp1p (spDcp1p) in complex with the S. pombe Dcp2p 
N-terminal domain (Dcp2NT, residues 1-95) was solved by single-wavelength 
anomalous dispersion from a Pb-derivative crystal at a resolution of 2.3 Å. There is 
one copy of the Dcp1p-Dcp2NT complex in the ASU, encompassing all but last three 
residues of Dcp2NT and residues 39-44 of Dcp1p (Figure 26a).  
The structure of spDcp1p is similar to that of scDcp1p. The difference between 
two structures lies in the N-terminal extension upstream of the EVH1 domain (Figure 
26b). In scDcp1p structure (Chapter 3.1.1), this region exhibits as an extended 
polypeptide (residues 17-25) plus  a short 310-helix (residues 26-30) in molecule B; 
while in molecule A, residues 22-31 forms a short α-helix with the first 21 residues 
being disordered. This N-terminal helix is the counterpart of helix α1 in spDcp1p. 
Moreover, two insertion regions that form the short helices and are specific to 
scDcp1p are absent in spDcp1p. The comparison of S. pombe Dcp2NT in the free and 
Dcp1p-bound forms shows that two structures are highly similar, especially in the 
helices α1-α4 (Chapter 3.2.1, Figure 26c). In the structure of the Dcp1p-Dcp2NT 
complex, α5 and α6 undergo moderate conformational change and tilt from the 















Figure 26. Crystal structure of the S. pombe Dcp1p-Dcp2NT complex. a) 
Ribbon diagram of Dcp1p (green) and the Dcp2 N-terminal domain (blue, 
Dcp2NT) in the complex. The helix α1 and loop of Dcp1p connecting strands β3 
and β4 are interacting with the helices α1 and α2 of Dcp2NT. b) Structural 
comparison of S. pombe Dcp1p (green) with molecule A (red) or B (magenta) of S. 
cerevisiae Dcp1p (1Q67). c) Comparison of the free (2A6T, orange) and Dcp1p-
bound Dcp2NT (blue) structures. 
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3.3.2 The protein-protein interface in the  Dcp1p-Dcp2NT complex 
spDcp1p associates with spDcp2NT via extensive hydrophobic interactions and 
hyd
ecapping but not in 
Dcp
wo conserved residues, Phe442 and Phe482 of helix 2, make contact 
with the pyrrolidine ring of Pro741. Moreover, the side chains of four residues: 
eu742-Trp782-Leu212-Ala172 form a long stretch of hydrophobic surface, 
ssociating with the one consisting of Arg81-Val111-Val151-Leu691 from Dcp1p.  
In agreement with the structural information derived from the Dcp1p-Dcp2NT 
complex, two temperature sensitive (ts) mutants dcp1-P74S and dcp1-L69S in S. 
pombe have been shown to be defective in mRNA decay at the non-permissive 
rogen bonding, burying a solvent accessible surface of 1016 Å2. The N-terminal 
helix α1 of Dcp1p bundles with helix α1 of Dcp2NT, and the Dcp1p loops connecting 
β3-β4 makes contact with part of α1 and α2 of Dcp2NT. All three conserved patches 
identified previously on scDcp1p are not involved in Dcp2p binding, which is 
consistent with the findings that these patches are involved in d
2p binding (Chapter 3.1.3).  However, the residues with moderate conservation 
are involved in Dcp2p binding. By contrast, Dcp2NT interacts with Dcp1p via a 
group of conserved residues, including the previously identified residues Arg18, 
Phe19 and Phe44, therefore confirming the findings that these residues are crucial in 
Dcp1p binding (Chapter 3.2.4). The details of residues engaged in protein-protein 
interaction were illustrated in Figure 27. 
Along the helix α1 of Dcp2NT, three invariant residues are all involved in Dcp1 
binding (residues are labeled with the subscripted 1 or 2, referring to Dcp1p or Dcp2p 
respectively): Asp142 forms a salt bridge with His191; Arg182 makes hydrogen 
bonding with Asn761; and Phe192 stacks between the hydrophobic side chains of 






temperature (Sakuno et al., 2004). Interestingly, Pro74 and Leu69 are both located in 
the β3-β4 loop of Dcp1p, suggesting that the phenotypes observed for these ts mutants 
could be due to their defects in Dcp2p binding in vivo.  
 
 
Figure 27. The protein-protein interface in the Dcp1p-Dcp2NT complex.  The 
ribbon diagram of α1 and α2 of Dcp2NT is shown in blue.  The ribbon diagram of 
α1 and β3-β4 loop of Dcp1p is shown in green. The residues involved in 
interaction are shown as sticks. Residues Arg18, Phe19 and Phe44 of Dcp2NT are 
underlined. 
 
 Dcp2NT Dcp1p 
4. Discussion 
4.1 




Comparison of putative PRS binding site of scDcp1p with other EVH1 
domains 
The structures of the yeast Dcp1 proteins revealed the core folding of the EVH1 
domain with external helices. All previously characterized EVH1 domains utilize a 
highly conserved cluster of surface-exposed aromatic residues to recognize the PRS 
ligands with remarkably low affinity but high specificity (Ball et al., 2002). All EVH1 
domains can be divided into three general classes based on their target PRS ligands, 
and the specificity is achieved by the variation of residues in the PRS binding site. 
Comparison of the putative PRS-binding site of Dcp1p with other EVH1 domains 
with known ligands helps to understand the characteristics of the site and to predict 
the sequence of a possible ligand. 
Mena, Homer and N-WASP are repr
H1 domains and the comparison of residue composition and arrangement has 
revealed some similarities and marked differences as well (Figure 28).  In scDcp1p, 
the potential PRS-binding site is lined with conserved aromatic residues including 
Trp49, Trp56, Leu190, Tyr47 and Trp204, of which only Trp56 is invariant in all four 
EVH1 proteins.  Trp49 of Dcp1p is analogous to Tyr16 of the Mena protein; Tyr47 
matches with Phe14 of Homer and Tyr46 of N-WASP; and Leu190 is the structural 
counterpart of phenylalanine of other EVH1 proteins. A unique feature of the Dcp1p 
pocket is Trp204, a highly conserved residue in all the Dcp1 proteins, but has no 
aromatic counterpart in other classes of EVH1 domains (Figure 11c). Thus 
rophobic surface is much extended in Dcp1p, consisting of five conserved 
residues instead of three in other EVH1 domains. This observation suggests that 
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Dcp1p may represent a novel class of EVH1 domain and has specificity distinct from 
that of other EVH1 domains towards ligands. 
 
Dcp1 vs Mena (Class I) Dcp1 vs Homer (Class II) Dcp1 vs N-WASP (Class III)
 
4.2 The Dcp1 and Dcp2 interaction in lower and higher eukaryotes 
In yeast, Dcp1p strongly associates with Dcp2p to form a holoenzyme with 
stimulated activity (Steiger et al., 2003). However, such direct interaction and 
activation effect were not observed with human or fly proteins in vitro (Lykke-
Andersen 2002; Cohen et al., 2005). This discrepancy is partly clarified based on the 
crystal structures of the S. pombe Dcp1p-Dcp2NT complex. As shown in Chapter 
3.3.2, although the surface of Dcp2p involved in Dcp1p binding is highly conserved, 
the residues in Dcp1p that are involved in Dcp2p association have a higher degree of 
variation in higher eukaryotes than in yeast. Only three out of nine spDcp1p residues 
depicted in Figure 27 are identical in hDcp1a, versus seven invariant residues in
scDcp1p. Accordingly, scDcp1p can form a heterogeneous complex with spDcp2n 
(residues 1-266) in vitro (data not shown). It is very likely that the protein-protein 
Figure 28. The potential ligand-binding site of scDcp1p. The comparison of PRS-
binding site in Dcp1 protein (cyan) with that of other EVH1 domain-containing 
proteins representing three classes of proline-rich sequences is shown in Cα traces.  
The side chains of conserved residues are shown as sticks.  
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interface seen in yeast is not pres ecies or that the affinity is weak. 
. In line with this view, H. sapiens protein Hedls or A. thaliana 
VA
ly and regulation of 5’ mRNA decay machinery 
mechanisms: by promoting the active conformation of the Dcp1p-Dcp2p holoenzyme 
erved in other sp
Thus Dcp1 and Dcp2 proteins in higher eukaryotes might adopt a different mode of 
interaction
RICOSE, which lacks a homolog in yeast, has been shown to bridge the 
interactions between the Dcp1 and Dcp2 proteins in human and plant respectively 
(Fenger-GrØn et al., 2005; Xu et al., 2006; Simon et al., 2006). The divergence of the 
decapping proteins interaction in yeast and human, together with the observation that 
the human P-body contains additional components, reflects the evolution and 
developing complexity of the RNA degradation machinery from lower to higher 
eukaryotes. 
 
4.3 Implication on the assemb
The Dcp1p-Dcp2p complex is part of the 5’ mRNA decay machinery residing in 
the cytoplasmic P-bodies, including Dhh1p, Edc1p, Edc2p, Edc3p, Pat1p and Lsm1-
7p, all of which are activators of decapping (Coller & Parker, 2004, Figure 29). In 
this study, several conserved surfaces on the Dcp1 and Dcp2 proteins are revealed, 
including patch 1 and patch 2 of Dcp1p and the conserved regions on the N-terminal 
domain and the Nudix domain of Dcp2p. Presumably, all or some of these surfaces 
are involved in binding other factors in the P-bodies.   
The 5’ decay factors participate at different steps of mRNA degeneration 
including translation repression, deadenylation and P-body formation (Coller & 
Parker, 2004). The interactions between these factors and the Dcp1p-Dcp2p complex 
suggest that mRNA degeneration is a coordinated and regulated process. And the 
activation effects on the Dcp1p-Dcp2p complex could be carried out through several 
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through protein-protein interaction; by reducing the inhibitory structures of mRNA; or 
by facilitating the access of the 5’ termini of mRNAs to the catalytic center. And the 
ructural and functional analysis on the Dcp1 and Dcp2 proteins in this study provide st
a molecular basis for further investigation in the field of mRNA decay study.  
m7Gppp
 
Figure 29. The model for mRNA decapping mechanism.  In the cytoplasm, the 
closed-loop mRNA serves as the template for protein synthesis. When translation 
is terminated, the poly(A) tail of mRNA is degraded by the deadenylase complex. 
The translation repressors, Pat1 and Dhh1 proteins, link the translation termination 
with the decapping step and mediate mRNA into the cytoplasmic processing body 
(grey area). The P-body factors, including Dcp1p, Edc3p, Lsm1-7p and Dhh1p-
Pat1p, regulate the decapping activity of Dcp2p through its conformational change 
to anchor the mRNA to the Box B region (blue crescent) and orient its 5’ cap to 
the active site (red star) for catalysis. When the cap is hydrolyzed, the m7GDP 
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